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	“The	nitrogen	in	our	DNA,	the	calcium	in	our	teeth,	the	iron	in	our	blood,	the	carbon	in	our	apple	pies	were	made	in	the	interiors	of	collapsing	stars.	We	are	made	of	starstuff.”			Carl	Sagan,	Cosmos								“Scientific	research	is	one	of	the	most	exciting	and	rewarding	of	occupations.	It	is	like	a	voyage	 of	 discovery	 into	 unknown	 lands,	 seeking	 not	 for	 new	 territory	 but	 for	 new	knowledge.	It	should	appeal	to	those	with	a	good	sense	of	adventure.”		Frederick	Sanger	
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Abstract			Mitochondria	 are	 cellular	 organelles	 responsible	 for	 energy	 conversion	 to	 form	 the	cell’s	energy	currency,	adenosine	triphosphate	(ATP),	through	the	process	of	oxidative	phosphorylation.	 In	 addition,	 mitochondria	 play	 a	 vital	 role	 in	 diverse	 cellular	processes	 including	 apoptosis,	 calcium	 homeostasis	 and	 intracellular	 signalling.	 As	 a	consequence,	mitochondrial	dysfunction	can	 lead	 to	numerous	disorders	 that	display	variability	 in	 clinical	 presentation	 and	 tissue	 specificity.	 Mitochondria	 contain	 their	own	 genome,	 known	 as	 mitochondrial	 DNA	 (mtDNA),	 and	 have	 distinct	 enzymes	involved	in	mtDNA	expression	and	maintenance.	Even	though	the	core	components	of	the	machinery	necessary	for	mtDNA	replication	have	been	identified	and	reconstituted	
in	vitro,	its	underlying	regulatory	mechanisms	are	largely	unknown.	The	displacement	(D)	 loop,	 a	 triple	 stranded	 structure	 that	 is	 formed	 by	 premature	 replication	termination	 generating	 the	 7S	 DNA,	 likely	 plays	 an	 important	 role	 in	 the	 control	 of	mammalian	mtDNA	replication	in	response	to	cellular	bioenergetics	demands.	The	 work	 described	 in	 this	 thesis	 aimed	 to	 study	 the	 effects	 of	 the	mitochondrial	 replicative	helicase	TWINKLE	and	 the	mitochondrial	 nuclease	MGME1	on	mtDNA	 replication	 regulation.	Both	of	 these	 factors	were	previously	described	 to	impact	7S	DNA	levels.		The	effects	of	TWINKLE	on	mtDNA	 levels	were	studied	by	generating	Twinkle	bacterial	 artificial	 chromosome	 (BAC)	 transgenic	mice.	This	TWINKLE	overexpressor	model	 showed	 that	 TWINKLE	 upregulation	 leads	 to	 an	 increased	 replication	 and	augmented	mtDNA	copy	number.			 To	 study	 the	 in	 vivo	 role	 of	 the	 MGME1	 nuclease	 in	 mtDNA	 replication	regulation,	Mgme1	knockout	mice	were	generated	and	analyzed.	Our	results	show	that	MGME1	is	not	essential	for	mouse	embryonic	development	and	survival.	This	MGME1	knockout	 model	 showed	 mtDNA	 depletion,	 and	 accumulation	 of	 an	 11-kb	 linear	mtDNA	 fragment	 that	 spans	 the	 entire	 major	 arc	 of	 the	 mtDNA	 and	 is	 present	 in	different	 mouse	 tissues.	 Interestingly,	 a	 similar	 linear	 fragment	 was	 also	 present	 in	
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mice	carrying	an	exonuclease	deficient	DNA	polymerase	(mtDNA	mutator	mice).	These	mice	show	a	progeroid	phenotype	that	is	likely	not	driven	by	linear	deletions	as	Mgme1	knockout	mice	do	not	display	a	premature	ageing	phenotype.		Finally,	we	dissected	the	role	of	MGME1	in	mtDNA	replication	and	transcription.	The	lack	of	abortive	replication	events	 and	 diminished	 H-strand	 transcription	 termination	 in	Mgme1	 knockout	mice	suggests	a	possible	role	of	MGME1	in	the	regulation	of	those	processes	at	the	end	of	the	D-loop	region.																																		
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Zusammenfassung		Mitochondrien	 sind	 essentielle	 Zellorganellen,	 die	 durch	 den	 Prozess	 der	 oxidativen	Phosphorylierung	 für	 die	 Energiegewinnung	 der	 Zelle	 in	 Form	 von	Adenosintriphosphat	 (ATP),	 zuständig	 sind.	 Zusätzlich	 spielen	 Mitochondrien	 eine	wesentliche	 Rolle	 in	 verschiedenen	 zellulären	 Prozessen,	 einschließlich	 Apoptose,	Kalziumhomöostase	und	intrazellulärer	Signalwege.	Daraus	folgt,	dass	mitochondriale	Dysfunktion	 zu	 einer	 Vielzahl	 von	 Funktionsstörungen	 führen	 kann,	 die	 eine	 ganze	Bandbreite	 von	 klinischen	 Befunden	 und	 gewebsspezifischen	 Auswirkungen	widerspiegeln.	Mitochondrien	besitzen	ihr	eigenes	Genom,	bekannt	als	mitochondriale	DNA	(mtDNA),	und	haben	eigene,	spezielle	Enzyme,	die	bei	der	mtDNA	Expression	und	Replikation	 involviert	 sind.	 Obwohl	 die	 Hauptkomponenten,	 die	 zur	 Replikation	 der	mtDNA	 benötigt	 werden,	 bekannt	 sind	 und	 in	 vitro	 rekonstruiert	 wurden,	 sind	 die	zugrunde	 liegenden	 regulatorischen	 Mechanismen	 weitestgehend	 unbekannt.	 Der	
Displacement	 (D)	 Loop,	 eine	 dreisträngige	 Struktur,	 die	 durch	 einen	 verfrühten	Replikationsabbruch	entsteht	und	aus	der	die	7S	DNA	hervorgeht,	spielt	vermutlich	in	Säugetieren	eine	wichtige	Rolle	bei	der	Kontrolle	der	mtDNA	Replikation	als	Antwort	auf	bioenergetische	Bedürfnisse.		 Die	hier	vorliegende	Arbeit	befasst	 sich	mit	der	Untersuchung	der	Effekte	der	mitochondrialen	 replikativen	 Helikase	 TWINKLE	 und	 der	 mitochondrialen	 Nuklease	MGME1	auf	 die	Regulation	der	Replikation	 von	mtDNA.	 In	der	Vergangenheit	wurde	bereits	für	beide	Faktoren	gezeigt,	dass	sie	die	Quantität	von	7S	DNA	beeinflussen.		 Die	 Auswirkungen	 von	 TWINKLE	 auf	 die	 mtDNA	 Level	 wurden	 anhand	 von	transgenen	 Mäusen,	 die	 Twinkle	 in	 einem	 künstlichen	 Bakterienchromosom	 (BAC)	tragen	 und	 überexprimieren,	 untersucht.	 Anhand	 dieses	 Modells	 konnte	 gezeigt	werden,	dass	die	Hochregulierung	von	TWINKLE	zu	einer	vermehrten	Replikation	und	erhöhten	Kopienzahl	von	mtDNA	führt.		 Um	die	in	vivo	Rolle	der	Nuklease	MGME1	während	der	Regulation	der	mtDNA	Replikation	zu	untersuchen,	wurden	Mgme1	knockout	Mäuse	generiert	und	analysiert.	Unsere	 Ergebnisse	 zeigen,	 dass	 MGME1	 für	 die	 Entwicklung	 und	 Vitalität	 von	
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Mausembryonen	nicht	essentiell	ist.	Die	Mäuse	des	MGME1	Knockout	Modells	zeigten	eine	Depletion	 der	mtDNA	und	 eine	 Akkumulierung	 eines	 linearen	 11-kb-Fragments	von	 mtDNA,	 welches	 den	 gesamten	 major	 arc	 der	 mtDNA	 	 umfasst	 und	 in	verschiedenen	Mausgeweben	präsent	ist.	Interessanterweise	gibt	es	ein	vergleichbares	lineares	 Fragment	 in	 Mäusen,	 die	 eine	 mutierte	 DNA	 Polymerase	 mit	 defizienter	Exonuklease	besitzen	(mtDNA	Mutator	Mäuse).	Diese	Mäuse	zeigen	einen	vorzeitigen	Alterungsphänotyp,	der	vermutlich	nicht	von	linearen	Deletionen	verursacht	wird,	da	dies	bei	Mgme1	knockout	Mäuse	nicht	der	Fall	ist.	Abschließend	untersuchten	wir	die	Rolle	 von	 MGME1	 sowohl	 bei	 der	 mitochondrialen	 Replikation	 als	 auch	 bei	 der	Transkription.	 Das	 Ausbleiben	 verfrühter	 Replikationsabbrüche	 sowie	 	 verminderter	Termination	der	H-Strang	Transkription	 in	Mgme1	 knockout	Mäusen	deutet	 auf	 eine	mögliche	Rolle	von	MGME1	bei	der	Regulation	dieser	wichtigen	Prozesse	am	Ende	der	D-Loop	Region	hin.											
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1.	INTRODUCTION	
	
1.1	Mitochondrial	origin		 Mitochondria	 are	 eukaryotic	 organelles	 that	 originated	 in	 an	 endosymbiotic	event	about	2	billion	years	ago1.	According	to	the	most	prevalent	hypothesis,	this	event	involved	a	facultative	anaerobic	α-protobacterium	and	a	hydrogen-dependent	archaeal	host	 able	 to	 respire	 in	 the	 presence	 of	 oxygen2.	 In	 this	 symbiotic	 relationship	 the	endosymbiont	provided	the	host	cell	with	ATP	in	exchange	for	carbohydrates3.		Additional	evidence	consequence	of	the	endosymbiotic	origin	of	mitochondria	is	the	presence	of	mitochondrial	genome	(mtDNA).	During	the	course	of	evolution	some	of	 the	ancient	genes	 from	the	endosymbiont	were	 transferred	to	 the	nuclear	genome	(nDNA),	 others	were	 lost,	 while	 yet	 others	were	 replaced.	 Interestingly	many	 genes	involved	in	mtDNA	replication	and	transcription	are	similar	to	bacteriophage	enzymes	and	have	probably	been	acquired	by	specific	horizontal	gene	transfer	events4.		Another	 interesting	 question	 in	mitochondrial	 evolution	 is	why	mitochondria	have	 retained	 their	 genome.	 One	 theory	 suggests	 that	 there	 is	 a	 need	 for	 a	minimal	mitochondrial	 genome	 to	 encode	 highly	 hydrophobic	 proteins	 that	 are	 difficult	 to	import	into	the	organelle.		When	encoded	by	mtDNA,	such	hydrophobic	proteins	can	be	synthesized	in	situ	and	any	import	difficulties	are	avoided.	In	support	of	this	theory,	the	mitochondrial	 highly	 conserved	 Cox1	 and	 Cytb	 genes	 encode	 some	 of	 the	 most	hydrophobic	proteins	present	 in	mitochondria5.	A	 second	 theory	 for	 the	 retention	of	mtDNA	 is	 based	 on	 the	 variations	 in	 codon	 usage	 between	 the	 nucleus	 and	 the	mitochondria,	 which	 may	 have	 prevented	 any	 further	 gene	 transfer	 from	 the	mitochondrion	 to	 the	nucleus6.	A	 third	 theory	 is	 the	 co-location	 for	 redox	 regulation	theory,	according	to	which	the	organelle	has	retained	the	genome	in	order	to	directly	regulate	the	expression	of	key	components	of	the	respiratory	electron	transport	chain	depending	on	the	intramitochondrial	redox	balance7,8.	In	support	of	this	latter	theory,	hydrogenosomes	 (degenerate	 mitochondria	 without	 ETC)	 have	 not	 retained	 their	genome.					
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1.2	Mitochondrial	function	and	form				 Mitochondria	 are	 enclosed	 by	 double	 membrane	 that	 separate	 two	 aqueous	compartments:	 the	 mitochondrial	 matrix	 and	 the	 intermembrane	 space9	 (Figure	 1).	The	outer	membrane	is	permeable	to	all	molecules	of	5000	daltons	or	less.	The	inner	mitochondrial	membrane	contains	an	extremely	high	protein	content	and	is	folded	into	invaginations,	creating	characteristic	cristae10.	The	five	complexes	of	the	mitochondrial	oxidative	phosphorylation	system	(OXPHOS)	are	located	in	the	inner	membrane.		 																		
Figure 1: Structure of mitochondria and biogenesis of the oxidative phosphorylation system 
(OXPHOS). Mitochondrial compartments: IM (inner membrane), OM (outer membrane), IMS 
(intermembrane space) and matrix. The majority of the OXPHOS subunits and other proteins 
involved in mitochondrial metabolism or mtDNA maintenance are nuclear encoded, translated on the 
cytosolic ribosomes and imported into mitochondria through specialized import machineries. 		
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The	matrix	 contains	 a	mixture	 of	 enzymes	 that	metabolize	 pyruvate	 and	 fatty	 acids,	and	 catalyze	 the	 citric	 acid	 cycle.	 Moreover,	 the	 matrix	 contains	 copies	 of	mitochondrial	DNA,	proteins	required	for	mtDNA	replication	and	expression,	and	mito-ribosomes11.		Mitochondria	 form	a	dynamic	 intracellular	network	and	have	an	essential	role	in	living	systems	by	performing	energy	conversion	to	produce	adenosine	triphosphate	(ATP)	 through	 the	 process	 of	 oxidative	 phosphorylation12.	 The	 OXPHOS	 system	 is	composed	of	five	complexes	(I-V)	and	consists	of	approximately	90	different	subunits.	Mitochondria	 can	 use	 both	 pyruvate	 and	 fatty	 acids	 as	 a	 fuel.	 Oxidation	 of	carbohydrates	in	the	citric	acid	cycle	and	lipids	via	β-oxidation	generates	the	electron	carriers	NADH	and	FADH2	which	donates	electrons	 to	 the	ETC13.	The	ETC	consists	of	four	 protein	 complexes,	 Complex	 I	 (NADH:	 ubiquinone	 oxidoreductase),	 complex	 II	(succinate:	 ubiquinone	 reductase),	 complex	 III	 (ubiquinol-cytochrome	 c	 reductase),	complex	IV	(cytochrome	c	oxidase).	All	of	the	complexes	are	under	dual	genetic	control	(mtDNA	and	nDNA)	except	complex	II	that	is	exclusively	nuclear	encoded14	(Figure	2).		
  
 
Figure 2: Schematic illustration of the structure and function the oxidative phosphorylation 
system. The OXPHOS system consists of five different enzyme complexes (Complexes I-V), and 
mobile carriers, coenzyme Q (CoQ) and cytochrome C. NADH and succinate are oxidized by 
complex I and II, the electrons are transferred to coenzyme Q, complex III, cytochrome C, complex 
IV and finally to molecular oxygen O2 which is reduced to water (H20). Protons are pumped out from 
mitochondrial matrix by complexes I, III and IV forming a proton gradient across the inner membrane. 
The protons return to the matrix trough ATP synthase and the energy of the proton gradient is used 
to drive ATP synthesis.  The	electrons	received	by	complex	I	and	II	are	passed	further	through	the	ETC	in	 a	 controlled	 series	 of	 redox	 reactions	 resulting	 in	 reduction	 of	 oxygen	 to	water15.	The	electron	transfer	via	ETC	is	coupled	to	the	transfer	of	the	protons	from	the	matrix	side,	 transferring	 them	 to	 the	 intermembrane	 space	 side	 thus	 creating	 an	electrochemical	 proton	 gradient	 across	 the	 inner	 membrane.	 This	 electrochemical	
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gradient	 is	 fully	 utilized	 by	 the	 fifth	 component	 of	 the	 OXPHOS	 system,	 the	 ATP	synthase	 or	 complex	 V,	 which	 by	 rotary	 catalysis	 combine	 ADP	 and	 phosphate	 into	ATP,	the	main	energy	currency	of	the	cell16,17.		Besides	 cell	 energy	 conversion,	 mitochondria	 are	 also	 crucial	 for	 other	biologically	 important	 functions	 including	 the	regulation	of	cellular	metabolism,	 fatty	acid	 β-oxidation,	 the	 citric	 acid	 cycle,	 formation	 of	 reactive	 oxygen	 species	 (ROS),	apoptosis,	 assembly	 of	 iron-sulphur	 clusters,	 and	 intracellular	 signalling18.	 As	 a	consequence	 of	 their	 critical	 roles,	 mitochondrial	 dysfunction	 is	 implicated	 in	many	rare	 human	 genetic	 disorders	 and	 diseases	 such	 as	 Parkinson’s	 and	 Alzheimer’s	disease,	diabetes,	as	well	as	the	ageing	process18.		
	
	
1.3	Organization	of	mtDNA				As	 a	 result	 of	 their	 endosymbiotic	 origin,	mitochondria	 have	 retained	 their	 genome,	and	eukaryotic	 cells	 contain	~103	 to	~105	 copies	of	mtDNA.	Mammalian	mtDNA	 is	 a	circular,	 double-stranded	 molecule	 of	 ~16.5kb.	 The	 mtDNA	 contains	 37	 genes	 and	encodes	 2	 ribosomal	 RNAs	 (rRNAs),	 22	 transfer	 RNAs	 (tRNAs),	 and	 11	 messenger	RNAs	(mRNAs)	(Figure	3).	The	individual	strands	of	the	mtDNA	molecules	are	referred	to	as	 the	heavy	 (H)	strand	and	 the	 light	 (L)	 strand	due	 to	 their	different	densities	 in	alkaline	 cesium	chloride	 gradients.	 Its	 only	 longer	non-coding	 region	 is	 the	 so-called	control	region	(non-coding	region	or	displacement	loop	(D-loop)	region,	which	harbors	regulatory	 elements	 for	 transcription	 and	 replication	 (the	 promoters	 for	 the	transcription	of	the	L	and	H	strands	(LSP	and	HSP)	and	the	origin	of	replication	of	the	H-strand	(OH)	(Figure	3).	However,	all	of	the	proteins	required	for	mtDNA	maintenance	and	 expression	 are	 encoded	 by	 the nuclear	 genome	 and	 have	 to	 be	 imported	 into	mitochondria	to	fulfill	their	function20.		The	 mtDNA	 is	 maintained	 in	 compact	 protein-coated	 structures	 known	 as	nucleoids,	with	a	mean	diameter	of	~100nm21.	In	addition	to	its	role	in	transcription,	TFAM	(mitochondrial	transcription	factor	A)	also	plays	a	key	role	in	mtDNA	packaging	into	 nucleoids22.	 Electron	 microscopy	 (EM)	 of	 biochemically	 in	 vitro	 reconstituted	nucleoids	 combined	with	 stimulated	 emission	 depletion	 (STED)	microscopy	 of	 fixed	cells	 showed	 that	 TFAM	 packages	 single	mtDNA	molecules	 in	 nucleoids	 that	 have	 a	
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slightly	ellipsoid	shape23.	TFAM	is	present	at	around	1000	copies	per	mtDNA	molecule	and	has	structural	properties	consistent	with	an	important	role	in	DNA	compaction24.	Among	the	other	suggested	nucleoid	associated	proteins,	some	assist	in	processes	such	as	 DNA	 replication	 and	 transcription25.	 Many	 different	 proteins	 involved	 in	mitochondrial	 biogenesis	 and	 metabolism	 are	 suggested	 to	 be	 recruited	 to	 the	nucleoids.	This	may	allow	mtDNA	packaging,	nucleoid	division,	and	 inheritance	 to	be	coupled	to	these	processes26.	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Organization of mtDNA. Non-coding regions harbor regulatory elements for transcription 
and replication. Transcription promoters: light-strand promoter (LSP) and heavy-strand promoter 
(HSP). Origins of replication: OH, origin of H-strand DNA replication and OL, origin of L-strand DNA 
replication. The tRNA genes encoded on each of the two strands are labeled with orange. mRNA 
and rRNA abbreviations: COI, cytochrome c oxidase subunit I; COII, cytochrome c oxidase subunit 
II; COIII, cytochrome c oxidase subunit III; Cytb, cytochrome b; ND1, NADH dehydrogenase subunit 
1; ND2, NADH dehydrogenase subunit 2; ND4, NADH dehydrogenase subunit 4; ND5, NADH 
dehydrogenase subunit 5, ATP6, ATP Synthase 6, ATP8, ATP Synthase 8,  ND6, NADH 
dehydrogenase subunit 6; 16S rRNA gene, 12S rRNA gene.  	
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1.4	Replication	of	mtDNA		 Replication	of	mtDNA	is	independent	of	the	cell	cycle	and	nDNA	replication,	and	mtDNA	 can	 be	 replicated	 several	 times	 or	 not	 at	 all	 during	 mitosis.	 Replication	 of	mtDNA	occurs	also	in	post-mitotic	cells,	as	mitochondrial	turnover	continues	in	order	to	 support	 their	 post-mitotic	metabolic	 requirements.	 Complex	machineries	 that	 are	required	for	faithful	mtDNA	replication	are	present	in	the	mitochondria	and	their	basic	components	 have	 been	 reconstituted	 in	 vitro27.	 Cooperation	 of	 the	 mitochondrial	heterotrimeric	 DNA	 polymerase	 (POLγ),	 the	 hexameric	 helicase	 TWINKLE,	 the	tetrameric	 mitochondrial	 single-stranded	 binding	 protein	 (mtSSB)	 and	 the	mitochondrial	RNA	polymerase	 (POLRMT)	was	 shown	 to	be	necessary	and	 sufficient	for	mtDNA	replication	in	a	recombinant	in	vitro	reconstituted	system27,28	(Figure	4).			 Numerous	 other	 factors	 may	 also	 play	 important	 roles	 in	 mtDNA	 replication.	Mitochondrial	 isoforms	of	 the	nucleases	RNaseH1,	FEN1	and	DNA2	are	 implicated	 in	replication	primer	removal	and/or	processing	of	the	DNA	flap	that	is	formed	when	the	replication	apparatus	has	 circled	 the	entire	mtDNA	molecule.	After	processing	of	 the	DNA	flap	 is	complete,	 the	mitochondrial	DNA	ligase	(DNA	ligase	III)	 ligates	the	5´and	3´nascent	DNA	ends	to	form	a	completed	circle21.	The	exact	mechanism	of	mtDNA	replication	is	still	a	matter	of	controversy	and	three	 different	 models	 have	 been	 suggested	 to	 date:	 a)	 the	 strand	 displacement	model29,	 b)	 strand-coupled	 model30,	 c)	 mtDNA	 replication	 via	 ribonucleotide	incorporation	throughout	the	lagging	strand	(RITOLS)	model31,32.											
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Figure 4: Components of the basic mtDNA replication machinery.  
 
 
1.4.1	The	strand-displacement	model				 Electron	 microscopy	 and	 atomic	 force	 microscopy	 analyses	 of	 replication	intermediates	 greatly	 contributed	 to	 the	 generally	 accepted	 strand-displacement	model	 (SDM)	 for	 mtDNA	 replication.	 This	 model	 proposes	 a	 unidirectional,	asymmetrical	synthesis	of	the	leading	H-strand	until	the	region	containing	the	origin	of	replication	 of	 the	 lagging	 L-strand	 is	 unwound	 initiating	 L-strand	 replication.	Furthermore,	 in	 support	 of	 the	 SDM,	 ChIP	 analysis	 of	mtSSB	 distribution	 in	vivo	 has	elucidated	 the	 additional	 role	 of	 mitochondrial	 single-stranded	 protein	 (mtSSB)	 in	covering	the	displaced	parental	H-strand	and	blocking	random	primer	synthesis	on	the	displaced	 strand.	 It	 was	 shown	 that	 this	 wrapping	 with	 mtSSB	 restricted	 POLRMT	activity	and	initiation	of	light-strand	mtDNA	synthesis.	The	finding	that	it	is	possible	to	initiate	 replication	 from	 OL	 in	 vitro33-35	 	 and	 that	 is	 impossible	 to	 mutate	 some	nucleotides	in	OL		in	vivo	lends	support	to	the	SDM	as	this	is	the	only	model	in	which	OL	has	a	proposed	function	as	a	origin	of	the	L-strand	replication34.			 The	origin	for	the	L-strand	replication	is	located	in	a	non-coding	region	of	~30	nt	and	 is	 flanked	 by	 five	 tRNA	 genes36.	 OL	 is	 activated	 when	 the	 growing	 daughter	 H-strand	synthesis	reaches	about	two-thirds	of	its	total	length,	displacing	the	parental	H-strand	as	a	single	strand.	After	strand	displacement,	OL	adopts	a	stem-loop	structure	
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and	 RNA	 priming	 starts	 at	 the	 T-rich	 region.	 Recent	 work	 suggests	 that	 L-strand	mitochondrial	 DNA	 replication	 is	 primed	 by	 mitochondrial	 RNA	 polymerase	(POLRMT)37.	 The	 biochemical	 analysis	 presented	 by	 Wanrooij	 and	 colleagues38	demonstrated	 that	POLRMT	has	 two	distinct	modes	of	action.	The	enzyme	efficiently	transcribes	 long	 regions	 of	 dsDNA,	 but	 becomes	 much	 less	 processive	 on	 ssDNA,	producing	only	short	RNA	molecules	of	25-75	nt.	The	short	RNA	primers	can	be	used	by	the	mitochondrial	DNA	polymerase	POLG	to	initiate	DNA	synthesis	in	vitro	and	this	reaction	 is	 stimulated	 by	 the	 mitochondrial	 ssDNA	 binding	 protein	 (mtSSB).	 It	 was	further	 demonstrated	 that,	 when	 combined,	 POLRMT,	 DNA	 polymerase	 POLγ,	TWINKLE	 and	 mtSSB	 are	 capable	 of	 simultaneous	 leading	 and	 lagging-strand	 DNA	synthesis	in	vitro.	Following	initiation	at	OL,	the	lagging	strand	synthesis	proceeds	over	the	whole	length	of	the	mtDNA	molecule	36.			 	
1.4.2	The	strand-coupled	model			 In	 addition	 to	 the	 SDM	 of	 replication,	 Holt	 and	 coworkers	 proposed	 an	alternative	 mode	 of	 mammalian	 mtDNA	 replication,	 the	 so-called	 strand	 coupled	model39.	This	model	for	mtDNA	replication	proposes	simultaneous	leading	and	lagging	strand	mtDNA	synthesis	and	it	is	based	on	observation	of	replication	intermediates	by	two-dimensional	 agarose	 gel	 electrophoresis	 (2D-AGE)39.	 According	 to	 the	 strand-displacement	 model,	 mtDNA	 replication	 starts	 bidirectionally	 from	 multiple	 origins	across	 a	 region	 including	 the	 CytB	 and	 ND5	 and	 ND6	 genes.	 When	 the	 replication	process	reaches	OH,	the	replication	fork	is	arrested	and	replication	is	restricted	to	one	direction	only40.		
1.4.3	RITOLS	model		 An	 additional	 model	 of	 replication	 called	 RITOLS	 mode	 (ribonucleotide	incorporation	throughout	the	lagging	strand)	was	proposed32.	This	model	differs	from	the	 strand	 displacement	 model	 by	 suggesting	 that	 the	 lagging	 strand	 is	 first	synthetized	as	an	RNA	molecule	that	 is	 later	replaced	by	DNA.	The	authors	speculate	that	the	RNA	may	help	to	protect	and	stabilize	the	displaced	ssDNA,	or	alternatively	act	to	block	transcription	machineries	that	could	interfere	with	the	replication	process31.			
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1.4.4	Mitochondrial	non-coding	region	(D-loop	region)		 The	mitochondrial	D-loop	or	non-coding	region	(NCR)	ranges	between	880	and	1400	bp	in	length,	and	in	its	5'	domain	it	contains	the	main	regulatory	elements	of	the	mitochondrial	genome:	the	two	promoters	(HSP	and	LSP)	and	the	origin	of	replication	of	the	H	strand.	Short	conserved	sequence	blocks	called	CSB1,	CSB2	and	CSB341	are	present	at	the	 NCR	 5’	 end	 .	 Those	 conserved	 sequences	 blocks	 are	 possibly	 involved	 in	 the	RNA:DNA	 transitions	 and	 formation	 of	 the	 RNA	 primers	 for	 H-strand	 replication.	Mitochondrial	 replication	 is	 coupled	 with	 transcription	 in	 mitochondria	 because	transcription	 from	 LSP	 terminates	 prematurely	 at	 the	 conserved	 sequence	 block	 2	(CSB2)42,43.	 This	 termination	 event	 generates	 an	 RNA	 replication	 primer	 of	 ∼100	 nt	(Figure	5).		A	remarkable	feature	of	mtDNA	replication	is	the	premature	termination	of	the	replication	of	the	newly	synthesized	H-strands	at	the	end	of	the	mtDNA	control	region	that	results	in	the	formation	of	a	~650	bp	long	structure	known	as	7S	DNA	or	D-loop44	(Figure	 5).	 Nearly	 95%	 of	 the	 H-strand	 initiation	 events	 are	 terminated	 in	 this	manner.29	 The	 D-loop	 structure	 is	 triple	 stranded	 since	 the	 newly	 replicated	 DNA	molecule	remains	bound	and	displaces	the	non-replicated	strand45.	The	half-life	of	the	D-loop	in	cell	culture	is	around	70	min,	which	shows	that	it	is	rapidly	turned	over29.		
	
Figure 5: Mitochondrial D-loop region with regulatory elements.  
 Important	roles	for	the	7S	DNA	have	been	proposed	in	mtDNA	replication	regulation,	maintenance	 of	 DNA	 topology,	 recombination,	 dNTP	 metabolism	 and	 nucleoid	
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segregation,	 but	 its	 exact	 function	 and	 the	mechanisms	 underlying	 its	 formation	 are	still	not	understood46.		In	 support	 for	 a	 regulatory	 role	 for	 the	 D-loop,	 the	 termination	 associated	sequences	(TAS	sequences)	composed	of	~15-bp	long	repetitive	conserved	sequences	are	 present	 at	 the	 end	 of	 the	 D-loop	 region45	 (Figure	 5).	 Furthermore	 two	 new	conserved	blocks	 of	 about	 60	 bp	were	mapped	 at	 the	 3’	 end	 of	D-loop	 region	 called	ETAS1	 and	 ETAS2	 (extended	 TAS	 sequences).	 Mapping	 such	 a	 region	 of	 conserved	sequences	 suggested	 their	 possible	 role	 in	multiple	 terminations	 signals	 functioning	between	mitochondrial	transcription	and	replication.	Potentially,	protein	factor(s)	that	are	binding	to	the	conserved	TAS	sequences	are	 leading	to	premature	DNA	synthesis	and	 7S	 DNA	 formation.	 In	 vitro,	 in	 organello,	 and	 in	 vivo	 footprinting	 approaches	 in	different	 mammalian	 species	 identified	 protein-binding	 sites	 at	 the	 3’	 region	 of	 the	control	region	of	mitochondrial	DNA.	Proteins	with	contrahelicase	activity	have	been	described	in	prokaryotic	and	eukaryotic	systems47,48.	In	sea	urchin,	the	mitochondrial	D-loop	binding	protein	 (mtDBP)	has	been	 shown	 to	bind	 to	 the	3’	 end	of	 the	D-loop	region,	to	display	contra-helicase	activity,	and	to	negatively	regulate	DNA	synthesis49.	In	Escherichia	coli,	the	replication	 termination	 factor	TUS	arrests	 the	 replication	 fork	via	 protein-protein	 interaction	 with	 the	 replicative	 helicase50.	 Moreover	 a	 48	 kDa	protein	 of	 unknown	 function	 has	 been	 reported	 to	 bind	 to	 ETAS	 sequences	 and	promote	7S	DNA	formation	in	bovine	mitochondria47.	However	no	TAS-binding	protein	in	mammals	has	yet	been	identified.		
1.4.5	Mitochondrial	DNA	polymerase	POLγ 		There	are	16	specialized	polymerases	present	in	mammalian	cells	required	for	nuclear	and	 mitochondrial	 genome	 maintenance.	 POLγ	 is	 a	 highly	 efficient	 and	 processive	polymerase	 located	 in	 mitochondria,	 and	 is	 responsible	 for	 mtDNA	 replication	 and	repair.	Disruption	of	 the	POLγ	 in	mice	causes	an	early	developmental	arrest	between	E7.5	and	E8.5	associated	with	severe	mtDNA	depletion,	confirming	its	essential	role	in	mtDNA	maintenance51.	POLγ	is	a	member	of	a	family	A	class	of	DNA	polymerases	which	also	 includes	 the	 E.	 coli	 DNA	 polymerase	 I	 and	 the	 T7	 DNA	 polymerase52.	 The	mammalian	 mtDNA	 polymerase	 holoenzyme	 is	 a	 heterotrimer	 with	 one	 catalytic	POLγA	subunit	and	two	accessory	POLγB	subunits.		
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The	POLγA	subunit	is	a	140	kDa	peptide	with	a	3’-5’	exonuclease	domain	that	is	connected	with	the	5’-3’	polymerase	domain	via	a	linker	region.	In	humans,	the	linker	region	is	a	482	amino	acids	long	region	and	mutations	in	this	region	have	been	linked	to	several	mitochondrial	disorders.	The	exonuclease	domain	has	proofreading	activity	during	replication	and	it	can	remove	inaccurately	incorporated	nucleotides53.	Recently	it	 has	 been	 reported	 that	 the	 exonuclease	 activity	 of	 POLγ	 is	 required	 for	 successful	DNA	ligation	in	the	final	step	of	mtDNA	replication	at	OH54.	Moreover	the	coordination	between	POLγ	and	newly	described	mitochondrial	nuclease	MGME1	has	been	shown	to	be	sufficient	for	flap	removal	and	ligation	to	complete	mtDNA	replication55.	Mice	that	have	 an	 exonuclease-deficient	 version	 of	 POLγ	 have	 increased	 levels	 of	 point	mutations,	linear	mtDNA	fragments,	and	develop	symptoms	of	premature	ageing56.		The	 accessory	 subunit	 POLγB	 has	 a	 molecular	 mass	 of	 55	 kDa.	 POLγB	 was	demonstrated	 to	 stimulate	 the	 catalytic	 activity	 and	 processivity	 of	 POLγA,	 by	enhancing	DNA	binding	and	increasing	the	polymerase	rate57.	POLγB	has	sequence	and	structural	similarities	with	the	anticodon-binding	pocket	of	the	prokaryotic	aminoacyl-tRNA	synthetases,	a	group	of	enzymes	that	catalyze	the	attachment	of	each	amino	acid	to	 its	 corresponding	 tRNA.	 The	 accessory	 subunit	 of	 DNA	 polymerase	 is	 present	 in	
Homo	 sapiens,	 Mus	 musculus,	 and	 Drosophila	 melanogaster,	 but	 is	 absent	 from	
Saccharomyces	cervisiae58.	The	protein	has	dsDNA	binding	activity	and	 is	 required	 to	ensure	that	the	polymerase	stays	bound	to	the	template	behind	the	moving	TWINKLE	helicase59.		In	conclusion,	the	role	of	POLγ	is	vital	for	mitochondrial	function,	and	defects	in	this	 enzyme	 are	 the	 most	 common	 cause	 of	 mtDNA	 stability	 disorders	 causing	conditions	 such	 as	 progressive	 external	 ophthalmoplegia	 (PEO),	 Alpers	 syndrome,	adult	onset	ataxia,	and	infertility.		
	
1.4.6	Mitochondrial	replicative	helicase	-	TWINKLE			 Helicases	 are	 universally	 present	 enzymes	 in	 prokaryotes,	 eukaryotes	 and	viruses	with	key	functions	in	DNA	and	RNA	metabolic	processes,	including	replication,	recombination,	 DNA	 repair,	 transcription	 and	 translation60.	 During	 DNA	 replication,	helicases	play	an	essential	role	in	unwinding	the	double-stranded	template	in	front	of	
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the	DNA	polymerase	and	the	resulting	ssDNA	strands	are	used	as	a	templates	for	the	synthesis	of	the	complementary	DNA	strands23.	The	mitochondrial	replicative	helicase	TWINKLE	unwinds	double-stranded	DNA	in	a	5’	->	3’	direction	using	NTP	hydrolysis	as	an	 energy	 source.	 This	 protein	 is	 homologous	 to	 the	 bacteriophage	 T7	 gene	 4	primase/helicase	(T7gp4	protein),	especially	 in	 its	helicase	domain.	 Interestingly,	 the		TWINKLE	protein	has	not	retained	the	primase	role	in	mitochondrial	replication,	hence	POLRMT	is	responsible	for	priming	DNA	synthesis	at	both	strands	61,37.		The	Twinkle	gene	was	originally	discovered	just	over	a	decade	ago,	in	an	screen	for	mutations	linked	to	autosomal	dominant	PEO	(adPEO)61.	Patients	with	this	human	disorder	 present	 exercise	 intolerance,	 muscle	 weakness,	 peripheral	 neuropathy,	deafness,	 ataxia,	 hypogonadism,	 and	 cataracts62.	 adPEO	 patients	 accumulate	 various	mtDNA	 deletions	 across	 different	 postmitotic	 tissues62.	 The	 TWINKLE	 protein	 is	comprised	of	a	carboxy-terminal	helicase	domain,	a	middle	 linker	domain,	 important	for	 subunit	 interaction	 and	 multimerisation,	 and	 an	 amino	 terminal	 domain	 of	unknown	function.61		Over	 30	 different	 TWINKLE	 mutations	 are	 known	 to	 cause	 accumulation	 of	deletions	or	depletion	of	mtDNA,	thereby	inducing	mitochondrial	energy	defects	which	result	in	neuro-muscular	symptoms63,64.	The	consequences	of	various	TWINKLE	mutations	have	been	studied	in	vitro	by	using	 recombinant	 proteins	 and	 expressing	 mutant	 protein	 versions	 in	 human	 and	insect	cell	lines65,66.	In	particular,	the	effects	of	adPEO-causing	mutations	in	the	linker	region	 have	 been	 studied	 as	 those	 show	 abolished	 protein	 hexamerisation	 and	DNA	helicase	 activity,	 which	 causes	 replication	 stalling.	 Overexpression	 of	 the	 mutated	
Twinkle	 in	 human	 cells	 showed	 mtDNA	 depletion	 and	 accumulation	 of	 replication	intermediates	and	also	induced	changes	in	nucleoid	structure	64,66,67.		Additionally,	 the	consequences	of	dominant	Twinkle-PEO	mutations	have	been	investigated	in	vivo	using	a	transgenic	mouse	strategy.	To	this	end,	a	so	called	Deletor	mouse,	which	 contains	 a	 transgene	 carrying	 a	 13	 amino	 acid-long	 duplication	 in	 the	TWINKLE	linker	region,	was	generated68.	In	this	model,	older	mice	expressing	the	PEO	linked	mutations	accumulate	mtDNA	deletions	in	muscle	and	brain,	and	show	a	cellular	phenotype	 similar	 to	 PEO	 patients	 with	 present	 aberrant	 mitochondrial	 structures.	These	mice	also	show	mtDNA	depletion	in	brain,	but	not	in	muscle	and	heart68.		
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Severe	phenotypes	in	patients	with	PEO	mutations	correlate	with	the	amount	of	residual	helicase	activity	in	Twinkle	mutants,	suggesting	that	proper	helicase	activity	is	required	 for	 TWINKLE	 to	 function64.	 Additionally	 to	 dominant	 PEO	 mutations,	 the	recessive	mutation	Y508C	has	been	described	in	the	helicase	domain	of	TWINKLE.	This	recessive	mutation	is	known	to	cause	IOSCA	a	form	of	 infantile-onset	spinocerebellar	ataxia69.	 From	 the	 analysis	 of	 patient	 cells	 and	 a	 homozygous	 IOSCA	 knockin	mouse	model,	 it	has	be	shown	that	IOSCA	is	associated	with	tissue-specific	mtDNA	depletion	in	the	 liver	and	cerebellum,	and	decreased	concentrations	of	all	dNTPs.	Furthermore,	IOSCA	mice	eventually	developed	mitochondrial	epileptic	encephalopathy,	mimicking	the	IOSCA	phenotype	seen	in	human	patients70.		Several	 mutant	 forms	 of	 TWINKLE	 have	 been	 expressed	 in	 Drosophila	
melanogaster,	 where	 they	 caused	 severe	 depletion	 of	 mtDNA	 and	 lethality65.	Mitochondrial	 impairment	 caused	 by	 these	 mutations	 promotes	 apoptosis65.	 This	observation	is	in	line	with	the	finding	that	in	vitro	depletion	of	TWINKLE	in	Schneider	cells	is	decreasing	mtDNA	copy	number71.		Finally,	 the	 in	vivo	 function	of	TWINKLE	has	been	 investigated	using	 a	mouse	model	72.	We	created	and	analyzed	conditional	Twinkle	knockout	(KO)	mice	and	proved	that	TWINKLE	is	the	only	mitochondrial	replicative	helicase	since	it	is	essential	for	the	mouse	 embryonic	 development72.	 Tissue-specific	 TWINKLE	 KO	 in	 the	 heart	 and	skeletal	 muscle	 of	 mice	 resulted	 in	 severe	 and	 rapid	 mtDNA	 depletion	 and	consequently	 decreased	 mitochondrial	 encoded	 transcripts	 and	 protein	 steady-state	levels.	Southern	blot	analysis	showed	that	TWINKLE	is	required	for	the	unwinding	of	the	 entire	 mtDNA	 molecule	 as	 well	 as	 for	 the	 abortive	 replication	 at	 the	 D-loop	region72.	
1.4.7	Mitochondrial	single-stranded	DNA	binding	protein	-	mtSSB		 A	 single-stranded	 DNA	 binding	 protein,	 mtSSB	 is	 present	 in	 mitochondria	 to	maintain	 integrity	of	 long	single-stranded	DNA	regions	during	replication.	mtSSB	 is	a	tetramer	that	consists	of	 four	16	kDa	subunits	and	shares	similarities	with	the	E.	coli	SSB	protein.	Besides	DNA	stabilization,	mtSSB	has	a	 stimulatory	effect	on	 the	 rate	of	DNA	 unwinding	 by	 TWINKLE27,73,	 probably	 due	 to	 a	 direct	 protein-protein	interaction74		
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1.4.8	Additional	proteins	involved	in	mitochondrial	DNA	replication		
	 The	 list	 of	 the	 proteins	 involved	 in	 mitochondrial	 DNA	 replication	 has	 been	expanded	during	recent	years.	Just	like	any	other	DNA,	mtDNA	requires	the	activity	of	various	enzymes	with	nuclease,	ligase,	and	topoisomerase	activities.		Topoisomerases	 are	 enzymes	 that	 adjust	 DNA	 topology	 for	 replication	 and	transcription	processes75.	Mitochondrial	topoisomerase	I	(TOP1mt)	transiently	breaks	one	DNA	strand	at	a	time	and	thereby	belongs	to	the	type	I	topoisomerases.	In	TOP1mt	knockout	 mice,	 an	 increased	 negative	 supercoiling	 of	 mtDNA	 indicates	 that	mitochondria	 contain	 an	 efficient	 topoisomerase	 activity	 that	 relaxes	 positive	supercoiling	of	DNA76.	Apart	from	TOP1mt,	two	additional	topoisomerases	(Top2α	and	Top2β)	were	shown	to	 localize	to	mitochondria	 in	mouse	and	human	models.	Top2α	and	Top2β	are	type	IIA	topoisomerases	-	 in	mitochondria	they	are	potentially	critical	for	 supercoil	 relaxation,	 enabling	 transcription	 and	 replication77,	 and	may	 also	 have	roles	in	decatenating	locked	mtDNA	circles	formed	during	replication76.		Ribonuclease	H1	(RNase	H1)	is	localized	in	both	the	nucleus	and	mitochondria.	Analysis	of	mtDNA	from	knockout	mouse	models	and	human	patient	studies	strongly	indicates	that	RNase	H1	removes	the	RNA	primers	at	the	origins	of	the	light	and	heavy	strand	 replication.	 Therefore,	RNase	H1	 is	 essential	 for	 proper	mtDNA	 replication	 in	humans,	and	pathogenic	RNaseH1	mutations	cause	mtDNA	replication	stalling,	mtDNA	depletion	and	deletions78.		DNA	 ligase	 III	 activity	 is	 present	 in	 mitochondria,	 and	 human	 cells	 with	impaired	 DNA	 ligase	 expression	 have	 reduced	 mtDNA	 copy	 number	 and	 multiple	single-stranded	 nicks79.	 Additionally,	 deletion	 of	 ligase	 III	 in	mice	 causes	 embryonic	lethality	 at	 E8.5,	 similar	 to	 the	 other	 mouse	 knockouts	 with	 germline	 disruption	 of	genes	essential	for	maintenance	or	expression	of	mtDNA80.		
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1.4.9	Mitochondrial	genome	maintenance	exonuclease	1	–	MGME1				 Recently,	 two	 different	 laboratories	 reported	 an	 exclusively	 mitochondrial	protein	called	mitochondrial	genome	maintenance	exonuclease	1	(MGME1	a.k.a.	Ddk1)	to	be	involved	in	processing	of	mitochondrial	DNA	during	the	replication81,82.	MGME1	belongs	to	the	RecB	subclass	of	PD-(D/E)XK	endonucleases	(Figure	6).	
  
Figure 6: Schematic representation of the MGME1 protein and localization of the investigated 
homozygous mutations causing disease. The motifs of the PD−(D/E)XK nuclease superfamily are 
indicated with Roman numerals. MTS indicates mitochondrial targeting signal. 
 Loss	 of	 function	 mutations	 in	 the	 gene	 encoding	 MGME1	 cause	 a	 severe	multisystemic	mitochondrial	disorder82.	The	mtDNA	from	muscle	of	affected	patients	shows	 various	 defects,	 including	 deletions,	 depletions,	 rearrangements,	 and	 7S	 DNA	accumulation83.	 In	 vitro	 analysis	 of	 recombinant	 MGME1	 showed	 that	 the	 protein	exhibits	5’-3’	nuclease	activity	with	a	specificity	for	single-stranded	DNA81,82.	It	shows	no	 activity	 on	 RNA,	 even	 when	 hybridized	 to	 DNA.	 In	 vitro	 nuclease-ligation	 assays	have	confirmed	that	MGME1	cleaves	longer	flaps	efficiently	but	imprecisely	around	the	flap	 base.	 The	 MGME1	 activity	 requires	 the	 3’-5’	 exonuclease	 activity	 of	 POLγ	 for	proper	 flap	 removal	 and	 nick	 ligation	 at	 OH55.	 Precisely	 processing	 the	 long	 primer	formed	at	OH	in	the	mitochondrial	NCR	may	require	a	teamwork	of	different	nucleases.	Initiation	 of	 mtDNA	 synthesis	 includes	 the	 RNA-DNA	 transition	 immediately	 after	CSB2,	but	the	5’	ends	of	the	nascent	DNA	are	moved	around	100	bp	downstream	of	the	transition	 site	by	presumably	a	 long-flap	pathway84.	 In	 support	of	 this,	7S	DNA	 from	MGME1	 deficient	 patient	 cells	 contains	 5’	 extended	 ends	 suggesting	 that	 Mgme1	
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activity	 is	 necessary	 for	 processing	 of	 the	 single-stranded	 flap	 intermediate83,84.	MGME1	patient	cells	also	contain	an	11	kb	truncated	linear	mtDNA	fragment,	the	ends	of	 which	 map	 near	 OH	 and	 OL	 suggesting	 that	 MGME1	 is	 involved	 in	 primer	 flap	processing	at	OH	83.	Interestingly	nucleases	like	FEN1	and	DNA2	may	also	have	roles	in	mtDNA	base	excision	repair	and	flap	processing	in	mitochondria85,86.	Therefore	it	has	been	 hypothesized	 that	 additionally	 to	 its	 exonuclease	 role,	 which	 is	 necessary	 for	proper	 replication	and	 flap	processing	 in	mitochondria,	MGME1	might	have	a	 role	 in	mtDNA	repair.	
1.5	Transcription	of	mtDNA		RNA	 synthesis	 in	 mammalian	 mitochondria	 is	 initiated	 from	 two	 different	promoters,	both	 located	 in	 the	D-loop;	LSP	and	HSP.	Transcription	of	 the	L-strand	 is	initiated	at	 the	LSP,	 resulting	 in	a	primary	 transcript	 encoding	mRNA-ND6	and	eight	tRNAs.	 Transcription	 of	 the	 H-strand	 produces	 a	 polycistronic	 transcript	 covering	almost	 the	 entire	H-strand87,88.	Almost	 all	 the	mRNA	and	 rRNA	genes	 are	 flanked	by	one	 or	more	 tRNA	 gene.	 Excision	 of	 tRNA	molecules	 is	 required	 to	 produce	mature	mRNA	 and	 rRNA	molecules	 from	 the	 polycistronic	 transcripts	 according	 to	 so-called	tRNA	punctuation	model89.		
1.5.1	The	basic	components	of	the	mitochondrial	transcription	machinery			 The	 basal	 transcription	 initiation	 machinery	 consists	 of	 three	 proteins:	mitochondrial	 RNA	 polymerase	 (POLRMT),	 mitochondrial	 transcription	 factor	 A	(TFAM),	 and	 mitochondrial	 transcription	 factor	 B2	 (TFB2M)90-92.	 Recently,	 a	transcription	elongation	factor	(TEFM)	was	reported	to	enhance	POLRMT	processivity	to	 produce	 large	 polycistronic	 transcripts	 covering	 almost	 the	 entire	 length	 of	 each	strand93,94.	POLRMT	 is	 a	 large	 single	 subunit	 enzyme	 of	 140	 kDa	 that	 shows	 a	 high	sequence	similarity	with	both	the	T3	and	T7	bacteriophage	polymerases.	It	is	the	only	RNA	 polymerase	 operating	 in	 mammalian	 mitochondria.	 Loss	 of	 POLRMT	 leads	 to	embryonic	lethality	at	E8.5,	as	seen	in	other	mouse	models	with	germline	disruption	of	genes	 essential	 for	 replication	 or	 expression	 of	mtDNA37.	 It	 has	 been	 confirmed	 that	
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POLRMT	is	essential	for	primer	synthesis	to	initiate	mtDNA	replication	also	in	vivo37.		Although	POLRMT	can	specifically	recognize	mitochondrial	promoters,	it	cannot	initiate	 transcription	 without	 assistance	 from	 two	 additional	 transcription	 factors,	TFAM	and	TFB2M90.	TFAM	belongs	to	the	high-mobility	(HMG)-box	family	of	proteins,	and	can	bind,	unwind	and	bend	DNA95.	The	vital	 importance	of	TFAM	for	mtDNA	maintenance	was	demonstrated	 in	 studies	 of	 homozygous	 TFAM	 knockout	 mice,	 which	 showed	embryonic	 lethality	 and	 severe	 depletion	 of	 mtDNA96.	 As	 one	 of	 the	 major	 protein	components	 of	 nucleoids,	 TFAM	 is	 likely	 to	 fully	 coat	 mtDNA21,97.	 TFAM	 binds	sequence-specifically	to	promoter	elements	immediately	upstream	of	the	HSP	and	LSP	transcription	 start	 sites.	 Structural	 studies	 showed	 that	 TFAM-binding	 introduces	sharp	U-turns	of	mtDNA,	which	may	facilitate	promoter	melting98.	The	DNA	bending	is	clearly	important	for	transcription	activation	and	previous	studies	indicate	that	the	C-terminal	tail	of	TFAM	plays	an	essential	role	in	transcription	activation99,100..	TFB1M	and	TFB2M	can	 assist	TFAM	and	POLRMT	during	 the	 initiation	of	 the	transcription	process.	TFB2M	is	more	active	in	stimulating	specific	transcription	as	is	TFB1M	 in	 vitro.	 Both	 factors	 are	 closely	 related	 to	 the	 family	 of	 bacterial	 rRNA	dimethyltransferases	 and	 our	 results	 suggest	 that	 TFB2M	 is	 a	 transcription	 factor	whereas	 TFB1M	 has	 no	 role	 in	 transcription	 but	 rather	 functions	 a	 12S	 rRNA	methyltranserase{Metodiev:2009dz}.	TFB2M	 is	 essential	 for	 complex	 formation	 during	mitochondrial	 transcription	initiation101,	and	crosslink	experiments	reveal	a	direct	 interaction	of	TFB2M	with	the	promoter	 starting	 site,	 where	 it	 is	 involved	 in	 promoter	 melting	 to	 facilitate	transcription	 initiation	 by	 POLRMT101.	 Additionally	 increased	 levels	 of	 TFB2M	activates	 mitochondrial	 transcription	 and	 causes	 elevated	 steady-state	 levels	 of	mitochondrial	 transcripts90,102	suggesting	a	direct	and	essential	 role	 in	mitochondrial	transcription.		TFB1M	was	shown	to	methylate	two	adenine	residues	in	a	conserved	stem	loop	region	of	the	12S	rRNA,	which	is	an	important	post-transcriptional	modification	in	the	process	of	mitochondrial	 ribosomal	biogenesis103,104.	Therefore,	TFB1M	 is	 thought	 to	have	 its	 main	 function	 in	 ribosomal	 maturation	 rather	 than	 in	 transcriptional	initiation104.		Recently,	 the	 transcription	elongation	 factor	 (TEFM)	was	 reported	 to	enhance	
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POLRMT	processivity	 by	 promoting	 the	 production	 of	 large	 polycistronic	 transcripts	covering	 almost	 the	 entire	 length	 of	 each	 strand93,94.	 Mitochondrial	 transcription	elongation	 factor	 (TEFM)	 interacts	 with	 the	 catalytic	 domain	 of	 POLRMT	 and	 its	depletion	 leads	 to	 a	 reduced	 transcription	 elongation	 and	decreased	promoter-distal	mitochondrial	 transcripts.	 Therefore,	 TEFM	 aids	 the	 transcription	 of	 longer	 RNA	products	and	the	circumvention	of	highly	structured	regions.	Furthermore	it	has	been	shown	 that	 interaction	 of	 the	 transcription	 elongation	 factor	 (TEFM)	 with	 the	mitochondrial	 RNA	 polymerase	 (POLRMT)	 and	 the	 nascent	 transcript	 prevents	 the	generation	 of	 replication	 primers,	 increases	 transcription	 processivity	 and	 thereby	serves	as	a	molecular	switch	between	replication	and	transcription93,105.		
1.5.2	Regulation	of	transcription	termination		
	 Mechanisms	 regarding	 mtDNA	 transcription	 termination	 in	 mammalian	organisms	are	still	under	debate.	Previously	 it	was	reported	 that	 transcription	of	 the	heavy	strand	is	 initiated	from	two	different	sites:	HSP1	and	HSP2106.	Transcripts	from	HSP1	were	proposed	 to	 terminate	 immediately	after	 the	16S	site,	while	 transcription	from	HSP2	promoter	continues	past	the	termination	site,	along	almost	the	entire	length	of	the	H-strand.	This	premature	termination	justified	why	HSP1	transcripts	resulted	in	a	 50-times	 higher	 abundance	 of	 rRNAs	 than	 mRNAs	 produced	 downstream	 of	 the	termination	 site107.	This	 termination	event	was	 suggested	 to	be	mediated	by	 specific	binding	of	mitochondrial	 termination	 factor	1	 (MTERF1).	However,	 in	vivo	 studies	 in	MTERF1	 knockout	 mouse	 reported	 that	 MTERF1	 blocks	 L-strand	 transcription	 to	prevent	 transcription	 interference	 at	 the	 light-strand	 promoter,	while	 not	 having	 an	effect	on	H-strand	transcription108.	Additional	roles	of	MTERF1	have	been	investigated	
in	vitro,	where	overexpression	of	MTERF1	causes	 replication	pausing.	These	 findings	have	 been	 confirmed	 after	 a	 recent	 study	 proposed	 a	 model	 where	 the	 MTERF1	binding	site	 is	a	pausing	site	 for	 the	replication	machinery	while	POLRMT	passes	the	rRNA	region.	After	the	halt,	the	transcription	machinery	can	remove	the	MTERF1	block	and	 replication	 can	 continue.	 Hence	 MTERF1	 acts	 as	 contrahelicase	 postponing	 the	progression	 of	 DNA	 replication	 and	 avoiding	 collisions	 between	 the	 replication	 and	transcription	 machineries	 in	 the	 rDNA	 region109.	 The	 MTERF	 protein	 family	 has	 an	
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important	 role	 in	 the	 regulation	 of	 mitochondrial	 transcription	 at	 the	 level	 of	termination	in	different	species.	In	addition	to	its	transcriptional	termination	activity,	mtDBP,	 the	MTERF1	homologue	 in	sea	urchin,	also	plays	a	role	 in	mtDNA	replication	acting	 as	 a	 contra-helicase,	 which	 negatively	 regulates	 mtDNA	 synthesis49.	 The	 L-strand	transcription	is	frequently	terminated	at	the	mitochondrial	non-coding	region,	at	 the	CSB1	and	CSB2	 sequences,	when	a	G-quadruplex	 structure	 is	 formed	between	the	nascent	RNA	and	the	non-template	DNA	strand.	Interestingly,	this	structure	covers	the	 3’	 end	 of	 the	RNA	primer	 formed	by	 premature	 transcription	 termination	 at	 the	CSB2	 site,	 and	 the	 primer	 appears	 inaccessible	 to	 the	 DNA	 replication	 machinery.	There	are	possible	additional	proteins	involved	in	resolving	this	hybrid	structure	and	enabling	utilization	of	the	RNA	primer	for	initiation	of	mtDNA	replication	at	OriH	110.		H-strand	 transcription	 is	 initiated	 from	 only	 one	 promoter	 and	 encompasses	nearly	 the	 entire	 mitochondrial	 genome	 with	 termination	 occurring	 in	 a	 region	immediately	upstream	of	the	tRNAPhe	gene,	at	the	termination	associated	sequences	in	the	 mitochondrial	 control	 region108.	 Recent	 findings	 suggest	 that	 termination	 of	 H-strand	 transcription	 and	premature	mtDNA	 termination	 at	 core-TAS	 are	 functionally	linked111.	 Further	 studies	 are	 necessary	 to	 elucidate	 the	 exact	 regulatory	 molecular	mechanisms	of	mitochondrial	transcription	and	replication	on	both	mtDNA	strands.		
	
1.6	Mitochondrial	DNA	repair		 The	mitochondrial	respiratory	chain	is	a	site	for	ROS	(reactive	oxygen	species)	and	RNS	(reactive	nitrogen	species)	production,	since	molecular	oxygen	can	differently	react	with	RC	electrons112.	ROS	are	generated	at	several	locations	in	the	cell,	but	90%	is	produced	 by	 the	 ETC	 in	 the	 mitochondria113.	 Imbalance	 between	 ROS	 and/or	 RNS	production	and	antioxidant	defense	mechanisms	can	lead	to	“oxidative	stress”,	which	is	highly	 harmful	 for	 cell	 functionality.	 Contrary	 to	 this	 detrimental	 role	 or	 ROS,	fluctuations	 in	 the	 steady-state	 levels	 of	 ROS	 have	 appeared	 important	 for	 cell	signaling,	 cell	 cycle	 progression,	 and	 apoptosis114.	 ROS	 consist	 of	 a	 variety	 of	 highly	reactive	 molecules	 and	 free	 radicals	 formed	 from	 reactions	 including	 molecular	oxygen.	One	of	the	most	common	ROS	species	is	the	superoxide	anion	(O2•–),	which	can	produce	hydrogen	peroxide	(H2O2)	in	a	reaction	catalyzed	by	superoxide	dismutases	or	via	 spontaneous	 reactions.	 H2O2	 can	 be	 further	 reduced	 to	 water	 or	 via	 a	 Fenton	
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reaction	converted	to	the	highly	reactive	hydroxyl	radical	(OH•).	In	mitochondria,	the	majority	of	O2•–	production	 is	 through	complex	 I	and	complex	 III115.	The	well-known	mitochondrial	 free	radical	theory	of	ageing	poses	that	ROS	produced	in	mitochondria	are	 a	 primary	 source	 of	 cellular	 free	 radicals	 contributing	 to	 the	 ageing	 process116.	Furthermore	 a	 “vicious	 cycle”	 has	 been	 suggested	whereby	 subsequent	ROS	 induced	mutations	in	mtDNA	would	accumulate	and	lead	to	dysfunctional	OXPHOS	components	that	 would	 produce	 more	 ROS	 and	 mtDNA	 mutations,	 finally	 resulting	 in	 cell	damage117.	 Therefore	 the	 main	 assertions	 for	 vulnerability	 of	 mtDNA	 and	 source	 of	mtDNA	 mutations	 are:	 a)	 proximity	 of	 mtDNA	 to	 OXPHOS	 system	 and	 exposure	 to	superoxide	 radicals	 b)	 lack	 of	 mtDNA	 repair	 mechanisms;	 and	 c)	 replication	 errors	during	normal	DNA	synthesis	 in	mitochondria.	Although	mtDNA	was	initially	thought	to	lack	repair	systems,	several	repair	pathways	have	recently	been	reported.		The	main	repair	pathway	found	in	mitochondria	is	base	excision	repair	(BER),	which	 includes	 single-nucleotide	 BER	 (SN-BER)	 and	 long-patch	 BER	 (LP-BER)118,119.	Initial	damage	recognition	and	cleavage	is	performed	by	the	specific	glycosylases,	and	mitochondria	 contain	 six	 damage-specific	 glycosylases.	UDG-uracil	DNA-glycosylase	 I	and	 OGG1-8-oxo-G	 DNA-glycosylase/AP	 lyase	 are	 expressed	 as	 both	 nuclear	 and	mitochondrial	 isoforms.	 Additionally	MUTYH	 and	NTH	 	 (thymine	 glycol	 glycosylase)	and	two	endonuclease	VIII-like	proteins	(NEIL1	and	NEIL	2)	are	reported	to	be	present	in	 mitochondria.	 After	 DNA-glycosylase	 cleavage,	 the	 DNA	 phosphate	 backbone	 is	cleaved	by	AP	endonuclease.	During	the	single-nucleotide	SN-BER,	POLγ	is	filling	single	nucleotide	gap	prior	to	ligation.	In	the	case	of	long	patch	LP-BER,	during	the	gap	filling	POLγ	is	displacing	the	5’DNA	strand	thus	creating	a	5’-flap	structure.	FEN1,	DNA2	and	EXOG	enzymes	were	implied	to	play	a	role	in	5’-flap	removal	prior	to	ligation84.	Long	patch	 repair	 is	mainly	 responsible	 for	 repairing	common	 lesions	caused	by	oxidative	damage	to	sugar-phosphate	backbone120.	Nucleotide	 excision	 repair	 (NER)	 has	 not	 been	 reported	 to	 operate	 in	mitochondria,	 even	 though	 many	 chemical	 carcinogens	 enter	 in	 mitochondria	 and	interact	with	mtDNA,	possibly	causing	large	lesions53.	Another	repair	mechanism	required	for	removal	of	base	mismatches	and	small	insertions	called	mismatch	repair	(MMR)	has	been	reported	to	operate	in	S.	serevisiae	and	 S.	 pombe121.	Regarding	 the	 MMR	 in	 higher	 eukaryotes,	 a	 low	 level	 MMR	 repair	
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activity	was	identified	in	rat	liver	mitochondrial	lysate122	but	the	main	MMR	enzymes	active	 in	 nucleus	 have	 not	 be	 identified.	Many	 recent	 studies	 that	 involve	 knockout	mouse	models	of	repair	enzymes	(MUTYH,	OGG1,	NEIL1)	develop	tumors123,	metabolic	syndrome124	 and	obesity125.	Additionally	disruption	of	OGG1/MYH	genes	 in	mice	did	not	result	 in	a	higher	mtDNA	mutation	rate126.	 In	 the	 future,	a	mitochondrial	specific	knockout	of	 these	repair	enzymes	can	contribute	to	the	 investigation	of	 their	specific	role	only	in	mitochondria.	Finally	many	of	the	proteins	playing	a	role	in	mtDNA	repair	are	also	implicated	in	mtDNA	replication	showing	tight	coordination	of	those	pathways	in	keeping	the	integrity	of	mtDNA.		
1.7	Mitochondrial	genetics	and	diseases	
	 Mitochondrial	 diseases	 are	 the	 most	 common	 causes	 of	 inherited	 metabolic	disease	 in	 humans	 with	 a	 frequency	 of	 about	 1	 in	 5000127.	 Human	 mitochondrial	disorders	encompass	a	genetically	heterogeneous	group	of	different	diseases,	 caused	by	 mutations	 in	 mitochondrial	 and/or	 nuclear	 DNA	 and	 display	 both	 clinical	heterogeneity	 and	 tissue	 specificity128,	 with	 the	 brain	 and	 muscle	 being	 the	 most	commonly	affected	 tissues129.	The	 inheritance	pattern	of	mtDNA-related	diseases	can	vary	 from	 case	 to	 case.	 Some	patients	 appear	 to	 be	 sporadic	 cases,	while	 others	 are	clearly	 inherited.	 Clinical	 heterogeneity	 can	 be	 explained	 by	 the	 specific	 features	 of	mtDNA	 genetics;	 since	mtDNA	 is	 maternally	 inherited,	 mutations	 in	mtDNA	 are	 not	transmitted	according	to	Mendelian	principles.	In	normal	cells,	most	mtDNA	copies	are	assumed	 to	 be	 identical,	 a	 condition	 know	 as	 homoplasmy.	 Pathogenic	mutations	 of	mtDNA	are	usually	present	only	 in	a	subset	of	all	mtDNA	molecules.	 	This	mixture	of	mutated	and	wild-type	mtDNA	molecules	is	called	heteroplasmy130.	
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Figure 7: Common clinical manifestations of mitochondrial disorders		 Very	often	the	proportion	of	mutant	and	normal	mtDNA	in	a	tissue	determines	the	clinical	outcome	of	the	mutation.	This	means	that	a	disease	or	biochemical	defect	will	be	caused	only	when	a	pathogenic	mtDNA	mutation	 is	above	a	certain	 threshold	level131.	This	 threshold	 level	 in	 turn	depends	on	the	mutation	type	and	tissue	energy	demand.	 Furthermore,	mtDNA	populations	undergo	 a	 bottleneck	 effect	which	means	that	only	a	small	proportion	of	the	total	number	of	mitochondrial	genomes	are	passed	on	 from	mother	 to	 offspring132.	 Therefore	 through	 this	 bottleneck	 effect,	 pathogenic	mutations	 can	 segregate	 to	 very	 different	 heteroplasmy	 levels	 in	 the	 offspring.	Consequently,	a	mother	carrying	a	pathogenic	mutation	can	give	birth	to	both	severely	sick	and	healthy	children130.					
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1.7.1	Mitochondrial	disorders	caused	by	mtDNA	mutations		 There	 are	 two	 major	 types	 of	 mtDNA	 defects	 that	 may	 occur:	 large	rearrangements	 (including	 deletions	 and	 duplications)	 and	 point	 mutations.	 The	defects	 can	 be	 present	 in	 the	 germline	 and	 be	 transmitted	 maternally,	 or	 appear	randomly	in	somatic	cells133.	Point	 mutations	 are	 the	 most	 predominant	 cause	 of	 disease	 in	 humans	 and	there	are	several	mitochondrial	disorders	know	to	be	induced	by	them.	Mitochondrial	encephalomyopathy,	 lactic	 acidosis	 and	 stroke-like	 episodes	 (MELAS)	 syndrome	 is	 a	multisystem	 disorder	 with	 impaired	 motor	 ability,	 vision	 and	 deficient	 cognitive	activity133.	MELAS	is	caused	by	a	few	point	mutations,	the	most	prevalent	of	which	is	an	A>G	 transition	 at	 m.3243	 in	 tRNALeu(UUR),	 but	 also	 in	 the	 ND5	 gene.	 Another	neuromuscular	disorder	known	as	myoclonus	epilepsy	with	ragged	red	fibers	(MERRF)		syndrome	 is	 a	 consequence	 of	 point	 mutation	 m8344	 A>G	 in	 tRNALys.	 	 The	 clinical	severity	 of	 MERRF	 correlates	 with	 heteroplasmy	 levels,	 and	 the	 biochemical	manifestations	of	MELAS	and	MERRF	are	seen	as	a	defect	in	complex	I	and/or	IV.	One	of	 the	 most	 common	 mtDNA-mutation	 disorders	 is	 Leber’s	 hereditary	 optic	neuropathy	 (LHON),	 characterized	 by	 subacute	 bilateral	 visual	 failure	 in	 young	adults134.	Usually	patients	carry	homoplasmic	point	mutations	m.3460	G>A,	m.11778	G>A	,	m14484	T>C	in	genes	coding	for	complex	I	subunits	of	the	RC.		Another	type	of	mitochondrial	DNA	mutations	are	mtDNA	rearrangements	that	are	 sporadic.	 Single	 large-scale	 deletions	 have	 been	 associated	 with	 progressive	external	 ophthalmoplegia	 (PEO),	 Kearn-Sayre	 syndrome	 (KSS)	 and	 Pearson’s	syndrome18.		
1.7.2	Mitochondrial	disorders	caused	by	nDNA	mutations	
	 Several	 diseases	 have	 been	 shown	 to	 be	 due	 to	 mutations	 in	 nuclear	 genes	encoding	mitochondrial	 proteins.	During	 the	 last	 decade,	 researchers	 have	 defined	 a	list	of	genes	 linked	 to	human	mtDNA	maintenance	disorders	mostly	affecting	mtDNA	replication.	Numerous	pathogenic	mutations	leading	to	mtDNA	instability	are	reported	in	 the	 genes	 encoding	 basic	 replication	 components	 such	 as	 POLGA,	 POLGB,	TWINKLE135,	and	replication/repair	related	factors	including	DNA2,	RNAseH1,	and	the	recently	 reported	 MGME1	 nuclease82,136,137.	 Mutations	 in	 these	 genes	 are	 causing	
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mtDNA	 depletion,	 accumulation	 of	 replication	 intermediates	 and	 stalled	 replication.	Typical	clinical	features	include	PEO,	characterized	by	muscle	weakness	affecting	most	severely	 the	 external	 eye	 muscle,	 exercise	 intolerance	 and	 loss	 of	 strength.	 Known	syndromes	include	Alpers	syndrome,	hepatocerebral	syndromes,	myopathies138.	Mitochondrial	DNA	depletion	syndrome	(MDS)	causes	mtDNA	depletion	 in	the	affected	tissue	and	many	mutations	in	many	genes	have	been	reported	to	be	associated	with	MDS:	TK2,	TYMP,	DGUOK,	RRM2B,	SUCLA2,	SUCLG1,	SLC25A4,	OPA1,	POLG,	POLG2,	
PEO1139.	 Besides	 these	 well	 characterized	 genes,	 mutations	 in	 the	 MPV17	 gene	encoding	 the	 mitochondrial	 inner	 membrane	 protein	 responsible	 for	 nucleotide	transport	or	the	ANT2	protein	involved	in	the	import	of	ATP	into	mitochondria,	have	been	associated	with	MDS	syndrome140,141.		Furthermore	mutations	affecting	respiratory	chain	protein	assembly	or	stability	encompass	a	large	group	of	mitochondrial	diseases.	Complex	I	and	IV	deficiencies	are		well-recognized	 biochemical	 defects	 in	 mitochondrial	 disorders.	 Several	 nuclear	mutations	were	identified	in	structural	or	assembly	subunits	of	complex	I	resulting	in	Leigh	 syndrome	 and	 diverse	 cardiomyopathies	 and	 encephalopathies.	 Similarly,	cytochrome	 oxidase	 deficiency	 mutations	 result	 in	 fatal,	 infantile	 diseases	 such	 as	Leigh	 syndrome,	 MELAS,	 congenital	 abnormalities	 and	 motor	 neuron	 disease-like	presentation62.					
																				
			 41	
	
2.	AIMS		 Replication	 of	mtDNA	and	mtDNA	 copy	number	 control	 are	 essential	 steps	 in	mitochondrial	 gene	 expression	 and	 may	 play	 a	 role	 in	 the	 regulatory	 processes	coordinating	 nuclear	 and	 mitochondrial	 gene	 expression	 in	 response	 to	 the	physiological	 demands	 of	 the	 cell.	 Despite	 the	 fact	 that	 the	 basic	 mitochondrial	replication	 machinery	 components	 are	 known,	 regulatory	 mechanisms	 controlling	mitochondrial	 replication	and	maintenance	are	still	 largely	unknown.	The	goal	of	my	PhD	 project	 is	 to	 gain	 further	 insights	 into	 mtDNA	 replication	 and	 its	 regulatory	mechanisms	 by	 generating	 and	 analyzing	 mouse	 models	 with	 altered	 mtDNA	replication.			 The	specific	aims	of	my	PhD	project	are:		 1.	 Characterization	 of	 the	 in	 vivo	 effects	 of	 TWINKLE	 overexpression	 using	 a	transgenic	mouse	model.		 2.	Unraveling	the	 in	vivo	role	of	the	MGME1	protein	in	mtDNA	maintenance	by	generating	and	analyzing	the	Mgme1	knockout	mouse	model.		
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3.	RESULTS		
3.1	Twinkle	overexpression	leads	to	elevated	mtDNA	levels		 The	 role	 of	 TWINKLE	 as	 the	 mitochondrial	 replicative	 helicase	 has	 been	demonstrated	 in	 vitro,	 where	 a	 combination	 of	 recombinant	 POLγ,	 mtSSB	 and	TWINKLE	 efficiently	 generated	 a	 DNA	 product	 of	 around	 16kb27.	 Our	 group	investigated	 the	 in	 vivo	 role	 of	 TWINKLE	 in	 mitochondrial	 replication	 and	 D-loop	synthesis	by	analyzing	Twinkle	knockout	mouse72.			To	 gain	 further	 insights	 into	 TWINKLE’s	 in	 vivo	 function	 and	 mtDNA	 copy	number	control,	we	investigated	the	effects	of	TWINKLE	overexpression	by	generating	
Twinkle	 bacterial	 artificial	 chromosome	 (BAC)-transgenic	mice.	The	advantage	of	 the	BAC-transgene	 method	 is	 the	 utilization	 of	 the	 large	 chromosome	 segments	 that	contain	the	chosen	gene,	its	endogenous	promoter	and	relevant	regulatory	sequences.	Therefore	transgene	expression	is	regulated	in	a	close-to-physiological	manner	in	the	mouse	typically	showing	moderately	increased	total	expression	of	the	studied	gene.		The	 transgenic	 animals	were	generated	 through	pronuclear	 injections	of	BAC	clones	 containing	 the	mouse	Twinkle	 gene,	modified	 for	 the	 genotyping	 purposes	 by	introduction	 of	 the	 XhoI	 silent	 mutation	 into	 exon	 1	 using	 BAC	 recombination	technology142	(Figure	3.1).			
 
 
Figure 3.1: BAC transgenic strategy. Wild-type (wt) Twinkle gene and Twinkle BAC transgenic 
locus with silent mutation introduced in exon I. Black dashes indicate positions of the primers in exon 
I used for genotyping.  
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The	 presence	 of	 BAC	 transgenic	 DNA	 was	 assayed	 by	 PCR	 combined	 with	restriction	enzyme	digestion,	and	electrophoretic	analysis	of	PCR	products.	Figure	3.2	A	 illustrates	 PCR	 performed	 on	 a	 TWINKLE	 BAC	 transgenic	 construct	 and	wild-type	DNA	followed	by	PCR	performed	on	subsequently	acquired	transgenic	(+/T)	and	wild	type	(+/+)	DNA.	Several	different	transgenic	mouse	lines	were	generated	and	one	line	showing	 stable	 and	 moderate	 TWINKLE	 overexpression	 in	 all	 analyzed	 tissues	 was	selected	 for	 further	 analysis.	 Upon	 analyzing	 mitochondria	 isolated	 from	 liver	 and	heart	tissues	of	wild-type	and	Twinkle	BAC	transgenic	mice	by	SDS-PAGE	and	western	blot,	 we	 detected	 two	 to	 three	 times	 higher	 TWINKLE	 protein	 levels	 in	 TWINKLE	overexpressing	 BAC	 transgenic	 mice	 (Figure	 3.2	 B).	 Furthermore,	 mitochondrial	transcription	 factor	 A	 (TFAM)	 levels	 were	 clearly	 elevated	 in	 mitochondria	 isolated	from	hearts	of	the	transgenic	mice	(Figure	3.2	B).		
	
Figure 3.2: TWINKLE BAC screening and protein levels. (A) Electrophoretic analysis of PCR 
products of control BAC construct and wild-type DNA(+/+) followed by PCR products of DNA isolated 
and digested from transgenic (+/T) and wild type (+/+) mice. (B) Western blot analysis of TWINKLE 
and TFAM levels in heart and liver mitochondrial extracts of TWINKLE overexpressing (+/T) and wild 
type (+/+) mice. VDAC was used as loading control. 		 It	has	been	suggested	that	TFAM	protein	levels	mostly	follow	mtDNA	levels143,	therefore	 the	 observed	 increase	 of	 TFAM	 protein	 levels	 in	 our	 model	 suggested	 an	upregulation	of	mtDNA	levels,	which	we	confirmed	using	Southern	blot	analyses.	Upon	quantification,	the	increase	of	mtDNA	levels	was	20–50%	(Figure	3.3).	
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Figure 3.3: mtDNA levels in TWINKLE overexpressor mice. Southern blot analysis and 
quantification of mtDNA levels in total DNA extracts from liver and heart from wild-type (+/+) and 
transgenic (+/T) mice. The nuclear 18S rRNA gene was used as a loading control. Error bars 
represent SEM 
	 Interestingly	 it	 has	 previously	 been	 reported	 that	 the	 effect	 on	 mtDNA	 copy	number	 and	 Twinkle	 mRNA	 levels	 is	 more	 profound	 in	 transgenic	 mice	 expressing	
Twinkle	under	 the	control	of	strong	β-actin	promoter,	where	mice	have	 three	 to	 four	transgenic	copies144.	As	the	Southern	blot	investigation	of	TWINKLE-overexpressor	animals	revealed	increased	mtDNA	levels	in	total	DNA	extracts	from	liver	and	heart,	we	next	tested	the	levels	of	mitochondrial	mtDNA	transcripts.	A	Northern	blot	analysis	of	mRNAs,	tRNAs	and	rRNAs	in	heart,	kidney	and	liver	tissue	of	TWINKLE	BAC	transgenic	mice	displayed	no	change	in	transcript	levels	compared	to	wild	type	animals	(Figure	3.4A).			 			
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Figure 3.4: Transcript levels and levels of respiratory chain complex subunits in TWINKLE 
overexpressor mice. (A) Northern blot analysis of mRNAs, tRNAs and rRNAs isolated from the 
heart, kidney and liver tissue of TWINKLE BAC transgenic 25 weeks old mice control (+/+) and BAC 
transgenic (+/T) mice. The nuclear 18S rRNA was used as a loading control. (B) Western blot 
analysis of steady state levels of respiratory chain complex subunits in TWINKLE BAC transgenic 
mice. Furthermore,	 we	 determined	 the	 steady	 state	 levels	 of	 protein	 subunits	 of	mitochondrial	 oxidative	 phosphorylation	 system	 (OXPHOS)	 enzyme complexes	 and detected	 no	 change	 in	 their	 levels	 (Figure	 3.4B).	 The	 SDHA	 protein	 subunit	 of	 the	respiratory	complex	II	was	used	as	a	loading	control,	as	all	components	of	this	complex	are	encoded	exclusively	by	nuclear	DNA128 	
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Figure 3.5: Western blot analysis in TFAM knockout and overexpressor mice. Western blot 
analysis of the steady-state levels of TWINKLE protein from isolated heart, liver and kidney 
mitochondria from TFAM knockout mice (L/L, cre) and their controls (L/L) and from human TFAM 
overexpressor animals (Tfam PAC). Transgenic animals (+/T); Controls (+/+). VDAC levels were 
used as a loading control. 
 Moreover,	we	also	assessed	TWINKLE	protein	levels	in	two	other	mouse	models	displaying	altered	mtDNA	levels.	Conditional	tissue	specific	knockout	of	TFAM	in	mice	causes	decreased	mtDNA	levels96,	as	seen	in	the	TWINKLE	knockout	mice.	In	contrast,	TFAM-overexpressor	mice	have	higher	 levels	 of	mtDNA,	which	was	 also	 observed	 in	the	 TWINKLE-overexpressor	 mice143.	 Transgenic	 mice	 in	 which	 human	 TFAM	 was	globally	overexpressed	by	utilizing	P1	artificial	chromosome	(PAC)	showed	increased	steady-state	 levels	 of	 TWINKLE	 in	 all	 analyzed	 tissues	 (Figure	 3.5).	 These	mice	 had	overall	 overexpression	 of	 TFAM	protein	 that	 resulted	 in	 40-70%	 increase	 of	mtDNA	copy	number.	Hence	upregulation	of	TWINKLE	protein	levels	in	TFAM	PAC	transgenic	mice	 suggests	 that	 enhanced	 mtDNA	 replication	 results	 in	 mtDNA	 copy	 number	upregulation143.	However,	heart	and	skeletal	muscle-specific	TFAM	knockout	mice	also	showed	 elevated	TWINKLE	 levels	 (Figure	 3.5).	 This	 effect	 could	 be	 explained	 by	 the	fact	that	replication	is	activated	as	a	compensatory	response	because	of	strong	mtDNA	depletion	in	those	mice.			
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3.2	Generation	and	verification	of	Mgme1	knockout	mice			
 
 
Figure 3.6: Mgme1 knockout mice. (A) Targeting strategy for disruption of the Mgme1 gene. (B) 
RT-PCR analysis result of Mgme1 transcripts from wild-type (+/+) and Mgme1 knockout mice (-/-) 
with primers in exons 2 and 4 (indicated on the scheme), left panel represents schematic 
representation of wild-type and knockout Mgme1 allele.  
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The	gene	encoding	MGME1	was	disrupted	in	the	mouse	by	utilizing	homologous	recombination	and	the	cre-loxP	system72.	Mgme1	exon	3	was	flanked	by	loxP	sequences	and	a	puromycin	cassette	(flanked	by	F3	sites)	was	 introduced	as	the	selection	marker	(Figure	3.6	A).	The	puromycin	selection	cassette	was	removed	by	mating	Mgme1+/loxP-pur	mice	with	transgenic	mice	ubiquitously	expressing	the	Flp-recombinase,	thus	generating	mice	heterozygous	for	a	loxP-flanked	Mgme1	allele.	Heterozygous	Mgme1	knockout	mice	were	 obtained	 (Mgme1+/-	 mice)	 after	 mating	 Mgme1+/loxP	 mice	 to	 mice	 ubiquitously	expressing	cre-recombinase	(beta-actin-cre	mice).	 Intercrossing	heterozygous	Mgme1+/-	animals	 gave	 viable	 homozygous	 knockout	 pups.	Mgme1	 homozygous	 knockout	 mice	appear	 healthy	 at	 least	 until	 12	 months	 of	 age,	 thereby	 indicating	 that	Mgme1	 is	 not	essential	for	mouse	embryonic	development.	Tissue-specific	(heart	and	skeletal	muscle)	
Mgme1	knockout	mice	(Mgme1loxP/loxP,	+/Ckmm-cre)	were	generated	by	mating	of	Mgme1+/loxP	mice	 with	 mice	 expressing	 cre-recombinase	 under	 the	 control	 of	 the	 creatine	 kinase	promoter	(Ckmm-cre).	The	tissue-specific	Mgme1	knockout	mice	appear	healthy	up	to	12	months	of	age	and	display	no	obvious	phenotypic	abnormalities	by	this	age.							
Figure 3.7: MGME1 protein levels in Mgme1 knockout mice. Western blot analysis of MGME1 
levels in heart mitochondrial extracts of MGME1 knockout (-/-) and wild type (+/+) mice. * non 
specific bend.  	 In	order	to	verify	the	gene	deletion	we	analyzed	Mgme1	knockout	animals	using	RT-PCR	(Figure	3.6B).	When	PCR	was	performed	on	cDNA	isolated	from	Mgme1+/+	and	Mgme1-
/-	tissue	using	specific	primers	in	exons	2	and	4,	amplification	in	knockout	animals	resulted	in	a	shorter	band	(214	bp)	indicating	absence	of	exon	3	(Figure	3.6B).	Western	blot	analysis	to	 assess	 the	 steady-state	 levels	 of	 MGME1	 protein	 showed	 the	 absence	 of	 the	 MGME1	protein	in	knockout	hearts	(Figure	3.7).		
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3.2.1	Mgme1	knockout	mice	display	multiple	mtDNA	deletions	and	
depletion	of	mtDNA	in	various	tissues		 Patients	carrying	homozygous	nonsense	and	missense	mutations	in	the	Mgme1	gene	 showed	 presence	 of	 mtDNA	 deletions	 in	 muscle,	 blood	 and	 urine	 samples82.	Therefore,	we	directly	investigated	for	the	presence	of	circular	mtDNA	molecules	with	large	 deletions	 by	 performing	 long-extension	 PCR	 on	 heart-isolated	 total	 DNA	 from	
Mgme1	 knockout	 mice.	 Primers	 were	 designed	 to	 amplify	 mtDNA	 molecules	 with	deletions	 in	 the	major	 arc	 of	 the	mtDNA	which	 is	 the	 region	between	 two	origins	 of	replication	and	most	commonly	affected	by	deletions	(Figure	3.8A	left	panel).	Indeed,	our	 results	 confirmed	 that	MGME1	 knockout	mice	 harbor	multiple	mtDNA	 deletions	(Figure	 3.8A).	 Moreover,	 Southern	 blot	 analysis	 of	 mtDNA	 levels	 of	 control	 (Mgme1	
L/L)	and	tissue-specific	knockout	mice	(Mgme1	L/L	cre)	as	well	as	control (Mgme1+/+)	and	homozygous	knockout	mice	(Mgme1-/-)	revealed	mtDNA	depletion	and	confirmed	the	presence	of	mtDNA	deletions	in	knockout	heart	tissue	(Figure	3.8B).		Using	 Sac	 I	 restriction	 enzyme	 digestions	 we	 confirmed	 that	 the	 deletions	correspond	to	an	11	kb	truncated	linear	mtDNA	fragment	between	the	two	origins	of	replication	OriH	and	OriL83.	Using	as	a	probe	a	radiolabelled	whole	mtDNA	molecule,	we	were	able	to	see	two	fragments	after	Sac	I	digestion	of	~7,1kb	and	~3,8kb	(Figure	3.8	B	left	panel).	This	confirmed	that	we	have	a	similar	sized	linear	fragment	in	Mgme1	homozygous	knockout	mice	 as	 in	patient	 fibroblasts.	We	used	DNA	 from	 the	mtDNA	mutator	 mouse	 (proof-reading-deficient	 version	 of	 PolγA,	 PolγA	 mut)	 as	 a	 control,	because	mutator	mice	have	an	increased	amount	of	a	similar	linear	mtDNA	deletion56.	Furthermore,	total	DNA	isolated	from	brain,	skeletal	muscle,	kidney	and	liver	of	control	 (Mgme1+/+)	 and	 homozygous	 knockout	 mice	 (Mgme1-/-)	 was	 analyzed	 by	Southern	blot	analysis.	The	mtDNA	levels	and	deletions	were	found	to	be	comparable	with	 those	 of	 heart	 tissue	mutants	 showing	 a	widespread	 tissue	 distribution	 of	 this	class	of	shorter	mtDNA	molecules	(Figure	3.9).		 	
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Figure 3.8: mtDNA levels in Mgme1 homozygous and tissue-specific knockout mice. (A) Long-
extension PCR of heart-isolated total DNA from 8 weeks old controls (+/+) and Mgme1 knockout 
mice (-/-) using primers amplifying major arc (indicated on scheme in left panel). (B) Southern blot 
analysis of SacI-digested heart mtDNA from control (Mgme1 L/L) and tissue-specific knockout mice 
(Mgme1 L/L cre), lanes 1 and 2; wild-type (+/+) and Mgme1 knockout mice (-/-) lanes 3-6, at 8 weeks 
of age, and control and mtDNA-mutator mice (lane 7 and 8).  
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Figure 3.9: mtDNA levels in Mgme1 homozygous knockout mice in different tissues. Southern 
blot analysis of SacI-digested DNA from brain, skeletal muscle, kidney and liver mtDNA from control 
wild-type (+/+) and Mgme1 knockout mice(-/-). 
			 52	
	
3.2.2	Mgme1	knockout	mice	have	an	increase	in	steady-state	levels	of	7S	
DNA	but	severely	diminished	de	novo	synthesis	of	7S	DNA			 It	 has	 been	 shown	 that	 fibroblasts	 from	 patients	 harboring	 mutations	 in	 the	
Mgme1	 gene,	 or	 cells	where	MGME1	 is	 down-regulated	 by	 small	 interference	 siRNA,	have	 two	 to	 eight-fold	 elevated	 levels	 of	 7S	 DNA.	 As	 discussed	 above	 in	 the	introduction	 section	 7S	 DNA	 represents	 pre-terminated	 nascent	 H-strand	 (~600nt)	that	 remains	 annealed	 to	 the	 template	 strand	 in	 the	 mitochondrial	 control	 D-loop	region	(Figure	5).	Its	function	still	remains	unknown.		Studies	 also	 reported	 that	 the	 degradation	 of	 7S	 DNA	 is	 impaired	 in	MGME1	deficient	 cells,	 rather	 than	 its	 synthesis83.	 We	 therefore	 performed	 in	 organello	replication	 experiments	 on	 mitochondria	 isolated	 from	 the	 heart	 of	 Mgme1+/+	 and	
Mgme1-/-	 animals	 to	 check	 the	 de	 novo	 7S	 DNA	 synthesis.	 Freshly	 isolated	 active	mitochondria	 from	 heart	 tissue	 were	 incubated	 for	 2	 hours	 with	 radioactive	 [α32P]	dATP	 to	 allow	 the	 incorporation	 of	 the	 radioactive	 nucleotide	 into	 the	 newly	synthetized	DNA.	We	also	performed	a	subsequent	1	hour	chase	to	follow	the	stability	of	de	novo	synthetized	mtDNA	and	7S	DNA.	Surprisingly,	we	could	not	identify	any	de	
novo	 synthesis	of	7S	DNA	 in	heart	mitochondria	 from	Mgme1	 knockout	mice	 (Figure	3.10A)	under	 this	experimental	condition.	As	a	control	we	used	 tissue-specific	 (heart	and	 skeletal	 muscle)	 Twinkle	 knockout	 mice	 (Twinkle	 L/L,	 cre)	 since	 these	mitochondrial	helicase-deficient	mice	have	a	strong	depletion	of	mtDNA	evident	from	a	young	 age	 due	 to	 lack	 of	 mtDNA	 replication72.	 Supporting	 the	 lack	 of	 essential	replicative	helicase	and	strong	mtDNA	depletion	 in	Twinkle	 knockout	mice,	we	could	not	detect	any	de	novo	synthesis	of	mtDNA	and	7S	DNA	in	those	mice.	Although	de	novo	7S	 DNA	 synthesis	was	 completely	 absent,	 we	 observed	 substantial	 levels	 of	 de	novo	mtDNA	 synthesis	 in	 control	Mgme1+/+	 and	 knockout	Mgme1-/-	 animals.	 Additionally	after	 a	 1h	 chase,	 it	 was	 noticeable	 that	 7S	 DNA	 has	 a	 much	 shorter	 half-life	 than	mtDNA,	 supporting	 previous	 data	 showing	 that	 the	D-loop	 has	 higher	 turnover	 then	the	whole-length	mtDNA145.		
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Figure 3.10: 7S DNA synthesis and steady-state level Mgme1 knockout mice.  (A) In organello 
replication in heart mitochondria isolated from 8-week-old control (+/+) and Mgme1 knockout (-/-) 
mice. De novo synthesized DNA was labeled using α-32P-dATP and separated by agarose gel 
electrophoresis. The chase experiment was performed for 1 hour and all samples were heated to 
93°C to release the 7S DNA strand (B) Southern blot analysis of 7S DNA levels in heart from control 
wild type (+/+) and Mgme1 knockout mice (-/-). The Nuclear 18S level was used as a loading control 
(C) Southern blot analysis of mtDNA and 7S DNA from ddC treated (+) or untreated (−) fibroblasts. 
Lane 1 untreated cells, lane 2 ddC treated cells for 3 days; lane 3 recovered cells for 2 days. 
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Figure 3.11: mtDNA and 7S DNA quantification in Mgme1 knockout mice (A) Quantification of 
7S DNA to mtDNA ration by previous Southern blot (Fig.3.10B) from mouse heart. The 7S DNA 
signal was normalized to the mtDNA signal; n = 2. Error bars indicate ±SEM (B) Quantification of 
mtDNA levels from Southern blot (Fig. 3.8B) from control (Mgme1 L/L) and tissue-specific knockout 
mice (Mgme1 L/L cre), lanes 1 and 2; wild-type (+/+) and Mgme1 knockout mice (-/-) lanes 3-6, n = 
3, Signals were normalized to the nuclear 18S signal. Error bars indicate ±SEM 
 	 Furthermore	 we	 performed	 Southern	 blot	 analysis	 to	 determine	 the	 steady-state	levels	of	7S	DNA	in	Mgme1	homozygous	knockout	mice	(Mgme1-/-)	in	comparison	to	their	wild-type	counterparts	(Mgme1+/+).	Interestingly,	we	saw	a	moderate	increase	in	the	ratio	of	7S	DNA	to	mtDNA	in	homozygous	Mgme1	knockout	mice,	when	we	take	in	account	around	50%	of	mtDNA	depletion	in	these	mice	(Figure	3.8B,	Figure	3.11	A	and	B),	which	 is	 not	 in	 full	 agreement	with	what	was	previously	 reported	 in	patient	fibroblasts82.	To	investigate	this	particular	discrepancy	between	de	novo	synthesis	and	steady-state	 levels	 of	 7S	 DNA,	 we	 followed	 the	 stability	 mtDNA	 and	 7S	 DNA	 after	inhibiting	the	de	novo	replication	by	use	of	the	non-hydrolysable	nucleotide	analog	ddC	in	Mgme1	knockout	mouse	embryonic	fibroblast	cultures	(MEFs)	(Figure	3.10.C).		After	 treatment	with	 the	 nucleotide	 analog	2′,3′-dideoxycytidine	 (ddC),	 under	the	conditions	where	new	DNA	molecules	can	not	be	synthetized,	wild-type	fibroblasts	showed	complete	lack	of	7S	DNA,	while	in	Mgme1	knockout	fibroblasts	a	certain	level	of	 7S	 DNA	 was	 maintained	 due	 to	 their	 increased	 stability	 (Figure	 3.10C).	 mtDNA	
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depletion	 caused	 by	 ddC	 is	 the	 result	 of	 inhibition	 of	mtDNA	 polymerase	 as	well	 as	termination	of	nascent	strand	elongation146.	Additionally	when	we	allowed	recovery	of	
Mgme1	knockout	and	control	MEFs	by	removing	ddC	we	could	not	observe	de	novo	7S	DNA	synthesis,	consistent	with	previous	results	showing	that	during	cellular	recovery	of	mtDNA	most	of	the	replication	events	are	productive111,147	(Figure	3.10C).			
3.2.3	MGME1	deficiency	results	in	accumulation	of	7S	DNA	with	extended	5	ends		
	 To	investigate	the	 influence	of	MGME1	deficiency	on	5’	and	3’	ends	of	7S	DNA	we	employed	 the	LM-PCR,	polyadenylation	and	primer	extension	on	mtDNA	 isolated	from	our	knock-out	mouse	model	(Figure	3.12).		
	
	
Figure 3.12: Mapping 7S DNA ends in Mgme1 knockout mice. (A) Agarose gel electrophoresis of 
LM-PCR and adenylation in heart from control wild type (+/+) and Mgme1 knockout mice (-/-). (B) 
Locations of the ends, determined by sequencing individual cloned PCR products in mouse heart 
mtDNA isolated from control (+/+) and Mgme1 knockout (-/-). 
			 56	
	 Sequencing	of	those	products	reveled	that	most	molecules	have	a	5´end	located	just	before	or	within	the	CSB1	sequence,	while	in	Mgme1	knockout	mice	5´	DNA	species	protrude	more	towards	the	CSB2	region	(Figure	3.12B).	These	data	are	comparable	to	the	data	from	human	patients83	and	support	the	function	of	MGME1	in	5’	end	mtDNA	processing.	 Additionally,	 3’	 end	 of	 7S	 DNA	 of	Mgme1	 knockout	 samples	 are	 mostly	mapped	upstream	of	tRNAPro,	similary	to	wild-type	controls.		
3.2.4	Lack	of	MGME1	affects	mitochondrial	transcription	differentially		
	 To	 investigate	 transcription	 in	 Mgme1	 knockout	 mice,	 we	 analyzed	mitochondrial	rRNA,	tRNA,	and	mRNA	steady-state	levels.	In	the	heart,	we	observed	a	decreased	abundance	of	mitochondrial	 transcripts	generated	 from	the	HSP	promoter	and	an	increase	of	promoter	proximal	transcripts	from	LSP	in	Mgme1	knockout	mice	(-/-)	 in	 comparison	 to	 control	wild-type	 (+/+)	mice.	 Interestingly	 LSP	promoter	 distal	transcripts	 did	 not	 change	 significantly	 in	Mgme1	 knockout	mice	 (Figure	 3.13	A).	 In	order	to	further	elucidate	MGME1’s	function,	we	performed	Northern	blot	analysis	to	determine	levels	of	7S	RNA	in	Mgme1	knockout	mice	(Figure	3.13	B).	We	could	observe	a	significant	decrease	in	7S	RNA	in	Mgme1	knockout	animals,	possibly	suggesting	that	the	 7S	 DNA	 de	 novo	 synthesis	 and	 transcription	 initiation	 at	 LSP	 are	 connected	processes.	 To	 investigate	 further	 MGME1’s	 role	 in	 the	 mitochondrial	 control	 region	replication	 regulation	we	have	 taken	 in	 account	 that	premature	H-strand	 replication	termination	 and	 transcription	 termination	 coming	 from	 the	 HSP	 promoter	 are	functionally	 linked111.	Therefore	we	performed	a	Northern	blot	analysis	using	strand	specific	 ribo	 probe	 specifically	 labeling	 anti-sense	 ACR	 transcript	 and	 we	 detected	large	 amounts	 of	 this	 transcript	 in our	 Mgme1	 knockout	 mice	 (Figure	 3.13	 C).	Previously	 reported	 5’	 ends	 of	 the	 ACR	 transcript	 were	 mapped	 to	 immediately	upstream	of	 tRNAP,	while	3’	ends	are	mapped	 immediately	upstream	of	 tRNAF148.	 In	this	experiment,	the	ACR	transcript’s	size	in	Mgme1	knockout	mice	has	been	estimated	at	<1	kb	on	the	basis	of	ND1	(956	bp)	and	COX1	(1542	bp)	transcript	sizes	in	the	same	experiment.	
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Figure 3.13: Steady-state transcript levels in Mgme1 knockout mice.  (A) Steady-state levels of 
mitochondrial mRNAs, rRNAs, and tRNAs; loading control is nuclear 18S rRNA (B) Northern blot 
analysis of 7S RNA levels in heart from control (Mgme1 L/L) and tissue-specific knockout mice 
(Mgme1 L/L cre) and Mgme1 knockout mice (-/-) and corresponding control (+/+) (C) The ACR 
transcript mapped by Northern blot analysis, using D-loop probe complement to the mtDNA light 
strand. ND1 and COX1 transcripts were added for ACR size assessment and 18S nuclear rRNA was 
used as a loading control.   
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To	 assess	 de	 novo	 mitochondrial	 transcription,	 we	 performed	 in	 organello	transcripts	labeling	in	isolated	mitochondria	from	control	and	Mgme1	knockout	hearts.	The	 levels	 of	 the	 newly	 synthesized	 transcripts	 from	Mgme1	 knockout	 hearts	 were	unchanged	in	Mgme1	(-/-)	mice	when	compared	with	wild-type	(+/+)	controls	(Figure	3.14A).	Nevertheless,	 if	we	consider	 that	Mgme1	 knockout	mice	display	mtDNA	 copy	number	 decrease,	 de	 novo	 transcription	 is	 upregulated	 in	 those	 mice.	 Mitohondria	isolated	 from	 TWINKLE	 tissue-specific	 knockout	 mice	 (Twinkle	L.L,	 cre)	 served	 as	 a	control	 in	 this	 experiment	 because	 those	 mice	 were	 previously	 reported	 to	 exhibit	severe	reduction	of	all	of	mitochondrial	transcripts72.	Additionally,	 we	 examined	 the	 steady	 state	 levels	 of	 transcripts	 encoding	various	proteins	involved	in	mtDNA	expression,	maintenance	and	repair	by	using	the	quantitative	 RT-PCR	 method.	 The	 levels	 of	 the	 transcript	 that	 encodes	 the	mitochondrial	 transcription	 factor	A	 (TFAM)	were	elevated	 (Figure	3.14C).	 Similarly,	the	 levels	 of	 transcripts	 encoding	 the	 mitochondrial	 DNA	 polymerase	 (POLG)	 were	increased	in	Mgme1	knockout	animals	(Figure	3.14D).	This	upregulation	of	TFAM	and	POLG	transcripts	might	be	a	compensatory	response	to	mtDNA	depletion	in	the	Mgme1	knockout	mice.	 	 Indeed,	 as	 a	 possible	 consequence	 of	 such	 an	mtDNA	depletion,	 the	levels	of	the	mtDNA-encoded	COX1	transcript	were	decreased	in	the	heart	tissue	of	the	
Mgme1	 homozygous	 knockout	 mice	 (Figure	 3.14D).	 Transcript	 levels	 of	 TWINKLE	replicative	helicase	and	levels	of	transcription	co-activator	PGC1-α	did	not	significantly	change	(Figure	3.14C	and	D).			We	 also	 checked	 for	 transcript	 levels	 of	 diverse	 nucleases	 (FEN1,	 DNA2)	reported	to	function	in	mitochondrial	flap	processing	during	mtDNA	repair,	 including	the	 endonuclease	 G-like	 (EXOG)	 in	Mgme1	 knockout	 animals,	 but	 did	 not	 detect	 any	significant	changes	(Figure	3.14B).	MGME1	transcripts	were	not	detectable	in	Mgme1	knockout	mice,	when	we	used	 a	TaqMan	detection	probe	 covering	 part	 of	 exon	3	 of	
Mgme1,	which	is	the	deleted	exon	in	our	knockout	model.		
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Figure 3.14: De novo and relative transcript levels in Mgme1 knockout mice. (A) In organello 
transcription in heart mitochondria isolated from 8-week-old control (+/+) and Mgme1 knockout (-/-) 
mice. De novo synthesized transcripts were labeled using α-32P-UTP and separated by agarose gel 
electrophoresis (B) Mitochondrial transcript steady-state levels assessed by qRT-PCR in hearts from 
8-week old Mgme1+/+ (gray bars) and Mgme1 knockout (-/-) (white bars) mice. Error bars represent 
SD. * p value < 0.05. ** p value < 0.01. *** p value < 0.001  
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3.2.6.	Mgme1	deficiency	causes	stalled	mtDNA	replication	close	to	OL	in	liver	and	
accumulation	of	replication	intermediates			 To	further	investigate	the	effect	of	MGME1	deficiency	on	mtDNA	replication,	we	used	 two-dimensional	 agarose	 gel	 electrophoresis	 (2D-AGE)	 to	 analyze	 putative	mitochondrial	 replication	 stalling	 and	 replication	 intermediates	 in	Mgme1	 knockout	mice.	 Higher	 amounts	 of	 stalled	 mtDNA	 replication	 intermediates	 were	 found	 in	patients	with	MGME1	nonsense	mutations,	as	well	as	for	patients	carrying	mutations	in	
Twinkle	and	PolgA	genes66,82.	Mgme1	knockout	hearts	showed	a	general	and	unspecific	accumulation	of	replication	intermediates	along	the	arc,	suggesting	that	replication	is	stalling	 throughout	 the	 restriction	 fragment	 (Figure	 3.16).	 Interestingly	 upon	knockdown	of	MGME1	in	cell	culture82	a	very	similar,	nonspecific	stalling	effect,	with	an	apparent	accumulation	of	replication	intermediates	was	reported	82.	Strikingly,	 liver	 tissue	 displays	 a	 different	 stalling	 pattern	 including	 a	 very	obvious	 spot	 in	 the	 knockout	 sample	 for	 the	 OL-containing	 fragment	 (Figure	 3.17B)	which	suggests	that	there	is	a	prominent	stalling	site	somewhere	in	the	vicinity	of	OL	in	the	Mgme1	knockout	mice	(Figure	3.17B).		
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Figure 3.16: Replication in heart of Mgme1 knockout mice. mtDNA replication in the heart of 
Mgme1 wild-type (+/+) and Mgme1 knockout mice (-/-) analyzed by two-dimensional neutral-agarose 
gel electrophoresis followed by Southern blot. Restriction enzymes and probes used (A)- OH  probe, 
(B)- OL probe) are indicated to the left. The black bars indicates the non-coding regions, and OH 
marks the origin of H-strand replication and OL denotes the origin of L-strand replication. The 
interpretation based on previous work is provided at the bottom left corner66.  
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Figure 3.17: Replication in liver of Mgme1 knockout mice. mtDNA replication in the liver of 
Mgme1 wild-type (+/+) and Mgme1 knockout mice (-/-) analyzed by two-dimensional neutral-agarose 
gel electrophoresis followed by Southern blot. Restriction enzymes and probes used (A)- OH  probe, 
(B)- OL probe) are indicated to the left. The black bars indicates the non-coding regions, and OH 
marks the origin of H-strand replication and OL denotes the origin of L-strand replication. The 
interpretation based on previous work is provided at the bottom left corner66 
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3.2.7.	Sequence	coverage	for	Mgme1	knockout	mice	from	different	tissues		 To	investigate	further	tissue-specificity	observed	by	2D	gels	we	performed	pair-end	sequencing	to	access	the	deletion	pattern	across	different	tissues.	As	a	control	we	used	 mtDNA-mutator	 mice	 known	 to	 have	 similar	 11	 kb	 deletion56,	 as	 do	 MGME1	deficient	patients	fibroblasts83	and	Mgme1	knockout	mice.	The	wild-types	for	Polγ	and	
Mgme1	 counterparts	 showed	 a	 similar	 sequencing	 coverage	 between	 all	 samples	 in	brain,	heart,	and	liver	tissue	(Figure	3.18	A,	B)	Figure	3.19	A,	B	black	lines).	For	POLγ	exo-nuclease	 deficient	 mice	 (mutator),	 mtDNA	 sequence	 coverage	 reveals	 control	region	multimers,	earlier	reported	in	heart	and	brain	in	these	mice149	(Figure	3.18A).	The	presence	of	a	linear	deletion	is	covered	by	a	large	control	region	sequencing	peak	(Figure	3.18A).		The	 coverage	 profiles	 of	 Mgme1	 knockout	 samples	 from	 brain	 and	 heart	displayed	similar	patterns,	including	a	pronounced	peak	of	7S	DNA	sequence	and	loss	of	sequence	coverage	in	the	direction	of	replication	(Figure	3.18	B	and	Figure	3.19	A).	In	contrast,	Mgme1	knockout	samples	from	the	liver	displayed	a	significant	decrease	in	sequence	 coverage	 in	 the	 region	 that	 corresponds	 to	 the	minor	arc	between	 the	 two	origins	of	replication,	and	also	showed	normal	levels	of	a	7S	DNA-like	sequence	(Figure	3.19	B).				
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Figure 3.18: Heart mtDNA pair-end sequencing from PolγAmut and Mgme1 knockout mice. 
Sequence coverage for the mouse mtDNA samples from heart (A) heart mtDNA from PolγAmut (B) 
heart mtDNA from Mgme1 knockout mice (-/-). Mitochondrial genome position (x-axis) versus 
sequence coverage divided by maximum coverage for each sample. The red lines correspond to 
mtDNA of PolγAmut mice or Mgme1 knockout mice (-/-), while black lines represent PolγAmut control 
and Mgme1 wild-type (+/+). Lines numbers correspond to samples number. The approximate 
locations of the origins of light-strand (OL) and heavy-strand (OH) replication are indicated by dotted 
lines with arrows. 	
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Figure 3.19: Brain and liver mtDNA pair-end sequencing from Mgme1 knockout mice. 
Sequence coverage for the mouse mtDNA samples (A) brain mtDNA from Mgme1 knockout mice (-/-
) (B) liver mtDNA from Mgme1 knockout mice (-/-). Mitochondrial genome position (x-axis) versus 
sequence coverage divided by maximum coverage for each sample The red lines correspond to 
Mgme1 knockout mice (-/-), while black lines represent Mgme1 wild-type (+/+). Lines numbers 
correspond to samples number. The approximate locations of the origins of light-strand (OL) and 
heavy-strand (OH) replication are indicated by dotted lines with arrows. 
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3.2.8	Steady-state	protein	levels	in	Mgme1	knockout	mice		
	 To	 further	 check	 the	 consequence	 of	 mtDNA	 depletion	 in	 Mgme1	 mutant	animals,	we	assessed	the	steady-state	protein	levels	of	respiratory	chain	subunits	and	various	 mitochondrial	 proteins	 (Figure	 3.20).	 The	 steady-state	 protein	 levels	 of	replicative	 helicase	 TWINKLE	 and	 transcription	 and	 mtDNA	 packaging	 factor	 TFAM	were	not	significantly	changed	in	MGME1	deficient	mice.	Additionally,	protein	levels	of	mitochondrial	 RNA	polymerase	 POLRMT	 as	well	 as	 levels	 of	 LRPPRC	 that	 binds	 and	stabilizes	mtDNA-encoded	transcripts,	were	not	affected	by	the	absence	of	MGME1	in	the	heart	 	 (Figure	3.20A).	MTERF1	protein	 levels	did	not	change	 in	Mgme1	knockout	mice	even	 though	recent	studies	have	revealed	a	new	MTERF1	role	 in	mitochondrial	replication,	 as	 a	 replication	 contrahelicase	 slowing	 DNA	 replication	 fork	 and	preventing	replication	transcription	machineries	collisions109	.		We	also	investigate	the	supramolecular	organization	of	the	respiratory	chain	by	the	BN-PAGE	technique.	Respiratory	chain	supercomplexes	were	resolved	by	BN-PAGE	and	visualized	by	in-gel	enzyme	activity	assays	for	complex	I	and	IV.	No	changes	in	the	levels	of	 respiratory	 complexes	 in	Mgme1	knockout	mice	were	detected	 (Figure	3.20	B).		 				
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Figure 3.20: Protein levels in Mgme1 knockout mice. (A) Western blot analysis of steady state 
levels of respiratory chain complex subunits and diverse mitochondrial protein in heart mitochondrial 
extracts from 11 and 27-week-old control (+/+) and Mgme1 knockout mice (-/-) mice. (B) In-gel 
enzyme activities of complexes I and IV in Mgme1 knockout and wild-type mouse. Coomassie 
staining of the BN gel was shown as a loading control. 			
			 68	
	
4.	DISSCUSSION			 Mitochondrial	DNA	replication	 is	an	essential	process	 that	must	be	performed	with	high	fidelity	and	may	be	controlled	at	multiple	levels.	The	enzyme	responsible	for	mtDNA	replication,	DNA	polymerase,	acts	in	coordination	with	a	number	of	additional	factors	 some	of	which	 can	behave	as	putative	 regulators	of	mtDNA	synthesis.	 In	 this	study	 we	 have	 investigated	 the	 in	 vivo	 role	 of	 two	 replicative	 factors	 (TWINKLE	helicase	and	MGME1	nuclease)	and	their	putative	function	in	regulation	of	mtDNA	copy	number	control.		More	 than	95%	of	 replication	 initiation	 events	 are	prematurely	 terminated	 at	TAS	sequences,	resulting	in	a	newly	synthetized,	around	650bp	long	7S	DNA	sequence	(prematurely	terminated	nascent	H-strand)	called	D-loop29.	The	mechanism	of	D-loop	formation	and	 its	role	are	currently	unknown.	One	suggested	role	 for	 this	premature	termination	event	is	that	it	can	act	as	a	regulatory	switch	to	block	or	release	full-length	mtDNA	 replication,	 thereby	 regulating	 mtDNA	 copy	 number.	 In	 support	 of	 this	regulatory	 role	 of	 D-loop,	 comprehensive	 analysis	 of	 control	 region	 sequences	 from	different	 mammalian	 orders	 mapped	 a	 conserved	 palindromic	 block	 of	 15	 nt-long	sequences	 -	 CSB1	 at	 the	 5’	 end,	 and	 core	 TAS	 sequences	 at	 the	 3’	 end	 of	 the	D-loop	region111.	 It	remains	possible	 that	 the	 fate	of	 the	replication	at	 the	end	of	 the	control	region	 is	 dependent	 on	 the	 interaction	 between	 basal	 replication	 components	 and	unidentified	 protein(s).	 Such	 protein(s)	 employing	 contrahelicase	 or	 some	 other	activity	may	be	crucial	for	the	disengagement	of	the	replication	machinery	at	the	end	of	the	D-loop	region	to	generate	abortive	replication.	There	are	many	examples	of	similar	proteins	 in	 prokaryotes	 and	 eukaryotes.	 In	E.	 coli,	 the	replication	 termination	 factor	TUS	 arrests	 the	 replication	 fork	 via	 protein-protein	 interaction	 with	 the	 replicative	helicase50.	In	eukaryotes,	nuclear	transcription	termination	factor	TTF-I	was	shown	to	display	 in	 vitro	 contra-helicase	 activity150.	 Furthermore,	 decrease	 in	 7S	 DNA	 was	observed	 in	 recovery	 time	 in	 cell	 culture	 after	mtDNA	was	 depleted	 using	 chemical	treatment,	 clearly	 indicating	 that	 the	 system	 can	 sense	 when	 there	 is	 a	 need	 for	productive	full-length	DNA	synthesis111.	Using	ChIP-sequencing	it	was	shown	that	the	replication	enzymes	POLγ	and	TWINKLE	are	highly	enriched	in	the	D-loop	region	but	at	 the	 3’end	 of	 the	 D-loop	 region	 POLγ	 is	 enriched	 in	 the	 absence	 of	 TWINKLE	
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suggesting	that	the	helicase	is	somehow	displaced	or	unloaded111.	This	unloading	could	be	a	consequence	of	contrahelicase	or	some	other	activity	displayed	by	protein	factor	binding	at	this	region	thereby	regulating	replication.	Similar	contrahelicase	activity	has	been	recently	reported	for	MTERF1	to	prevent	head-on	collisions	between	replication	and	transcription	machineries	in	the	rDNA	region	in	mtDNA109.				 In	order	to	get	further	insights	in	mtDNA	copy	number	control,	we	assessed	the	effect	 of	 TWINKLE	 overexpression	 on	 the	 mtDNA	 copy	 number	 and	 mitochondrial	function	by	generating	and	studying	Twinkle	BAC	transgenic	mice.	The	BAC	transgenic	strategy	employed	assured	moderate	 increase	 in	TWINKLE	 levels	 (~2-3x)	 that	 led	 to	mildly	elevated	mtDNA	copy	number	(~20–50%)	in	the	transgenic	mice.	However,	this	mtDNA	 copy	 number	 increase	 did	 not	 have	 any	 downstream	 consequences	 on	 the	steady	state	 levels	of	mitochondrial	encoded	transcripts	and	proteins.	A	more	drastic	effect	of	Twinkle	overexpression	on	mtDNA	levels	(~3x)	has	been	described	previously	by	β-actin	promoter	driven	overexpression144.	Using	an	 in	vivo	BrdU	labeling	strategy	and	the	same	previously	mentioned	mouse	model,	the	authors	showed	that	TWINKLE	specifically	 regulates	 de	 novo	 mtDNA	 synthesis151.	 Remarkably,	 when	 we	 have	analyzed	 another	mouse	model	 displaying	mtDNA	 copy	 number	 increase,	 the	 TFAM	overexpressor	 mice148,	 we	 also	 found	 elevated	 TWINKLE	 steady-state	 levels	 in	 all	analyzed	 tissues,	which	 is	consistent	with	 the	general	 idea	 that	mtDNA	copy	number	upregulation	 is	 the	 result	 of	 increased	 mtDNA	 replication.	 Furthermore,	 Twinkle	knockout	mice	 analyzed	 in	 our	 laboratory	 displayed	 severe	mtDNA	depletion72.	 This	interdependence	between	TWINKLE	and	mtDNA	levels	points	towards	an	active	role	of	TWINKLE	in	mtDNA	copy	number	regulation.		Next,	we	studied	the	role	of	MGME1	in	mtDNA	replication.	Mgme1	gene	is	new	on	 the	 list	 of	 genes	 linked	 to	 human	 mitochondrial	 DNA	 maintenance	 disorders82.	Previous	studies	have	extensively	characterized	MGME1	 in	vitro	nuclease	activity81-83.	Moreover,	analysis	of	Mgme1	patient	fibroblasts	isolated	from	Mgme1	 loss	of	function	patients	demonstrated	its	involvement	in	the	mtDNA	replication	process81-83.		Here	we	have	investigated	the	in	vivo	function	of	the	mtDNA	nuclease	MGME1	by	creating	and	characterizing	mouse	knockout	models	(whole	body	and	tissue	specific	-heart	 and	 skeletal	 muscle	 mouse	 knockout).	 MGME1	 is	 not	 essential	 for	 the	 mouse	embryonic	development	since	Mgme1	homozygous	knockout	mice	are	viable	and	appear	healthy	until	at	least	year	of	age.	Heart	and	skeletal	muscle	specific	knockout	animals	of	
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MGME1	also	do	not	develop	any	obvious	morphological	phenotype	until	week	70	of	age.	Long-extension	PCR	and	Southern	blot	analysis	showed	the	presence	of	multiple	mtDNA	deletions	and	mtDNA	depletion	in	all	analyzed	knockout	mouse	tissues,	which	is	in	line	with	 results	 obtained	 from	 muscle	 biopsies	 from	 individuals	 affected	 with	 MGME1	mutations.	 A	 linear,	 11-kb	 mtDNA	 fragment	 that	 spans	 the	 entire	 major	 arc	 of	 the	mtDNA	is	a	hallmark	of	MGME1	deficiency	in	both	patients	and	mice83.	 Interestingly,	a	similar	11	kb	linear	fragment83,84	is	found	also	in	POLγA	exonuclease	deficient	(mtDNA	mutator)	mice56.			 					
	
Figure 4.1: Origin of the linear deletion. Model of generation of an 11 kb linear mtDNA fragment. 	It	has	been	shown	that	the	proofreading	activity	of	POLγ	is	required	for	the	creation	of	ligatable	ends	during	mtDNA	replication54.	Due	to	MGME1	nuclease	deficiency	or	POLγ	A	 exo-deficiency,	 an	 abnormal	 replication	product	 arises	due	 to	 the	 failed	 ligation	of	the	nascent	H-strand	at	OH84.	Precisely,	when	POLγ	 reaches	 the	5′-end	of	 the	nascent	strand,	a	transient	5′-flap	is	formed.	If	this	flap	is	not	processed	due	to	an	exonuclease-deficient	 POLγ	 strand	 displacement,	 or	 because	 of	 an	 MGME1	 nuclease	 deficiency,	ligation	will	fail,	resulting	in	a	daughter	molecule	with	a	nick	on	the	H-strand	near	the	OriH	site.	During	the	next	round	of	replication,	the	L-strand	replication	will	terminate	when	the	nick	on	the	H-strand	is	reached,	leading	to	a	double	stranded	DNA	(dsDNA)	break	near	OriH84	(Figure	4.1).	This	results	in	a	linear	fragment	that	spans	between	the	two	origins	of	replication.		The	 data	 presented	 in	 this	 thesis	 demonstrate	 that	Mgme1	 knockout	 hearts	show	 a	 general	 and	 unspecific	 accumulation	 of	 replication	 intermediates	 along	 the	replication	 arc,	 suggesting	 that	 replication	 is	 stalling	 along	 the	 entire	 restriction	fragment.	 This	 result	 was	 different	 to	 what	 was	 seen	 in	 liver	 tissue,	 where	 a	 very	prominent	 stall	 site	 was	 observed	 somewhere	 in	 the	 vicinity	 of	 OL	 in	 the	 Mgme1	
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knockout	 mice.	 Interestingly,	 knockdowns	 of	 MGME1	 in	 cell	 culture82	 reveal	 a	 very	nonspecific	stalling	effect,	with	an	apparent	accumulation	of	replication	intermediates	everywhere,	 similarly	 to	Mgme1	 knockout	 hearts.	 Therefore,	 the	 in	 vivo	 process	 of	replication	stalling	observed	in	our	mouse	model	in	the	heart	is	in	agreement	to	what	has	been	previously	reported	from	 in	vitro	MGME1	patient	 fibroblasts	and	HeLa	cells	where	 MGME1	 was	 depleted	 (siRNA).	 In	 contrast,	 the	 in	 vivo	 replication	 stalling	process	in	the	liver	of	Mgme1	knockout	mice	is	quite	distinct	and	shows	different	site-specificity	 to	 that	 previously	 reported	 from	 in	 vitro	 MGME1	 human	 fibroblasts	 and	HeLa	cells82.	Furthermore,	pair-end	 sequencing	of	Mgme1	 knockout	 samples	 from	 the	 liver	showed	 a	 sequence	 coverage	 curve	 that	 likely	 reflects	 the	presence	of	 linear	mtDNA	molecules	 with	 a	 large	 deletion.	 A	 similar	 sequence	 coverage	 has	 been	 previously	reported	from	liver	mtDNA	mutator	mice164.	Interestingly	mtDNA	mutator	sequencing	from	 heart	 resulted	 in	 control	 regions	 coverage	 increases.	 Similar	 results	 have	 been	shown	 in	a	 study	 that	 investigated	 the	abundance	of	heteroplasmic	SNVs	using	high-coverage	next-generation	sequencing	 in	mtDNA	mutator	mice149.	They	reported	2-	 to	4-fold	 increase	 of	 sequence	 coverage	 in	 control	 region	 in	 the	heart	 and	brain.	 These	sequences	 are	 denoted	 as	 control	 region	 multimers,	 comprising	 multiple	 copies	 of	sequence	around	 the	5’	end	of	 the	mtDNA	control	 region149.	The	coverage	profiles	of	
Mgme1	knockout	samples	from	brain	and	heart	displayed	a	similar	pattern	including	a	pronounced	peak	of	7S	DNA	sequence	and	loss	of	sequence	coverage	in	the	direction	of	replication.	These	differences	between	 the	 liver	 and	 the	heart	 are	corroborated	with	2D-AGE	gel	data	from	these	tissues.	The	elevation	in	sequencing	reads	along	the	major	arc	in	the	liver	indicates	that	replication	has	trouble	getting	past	OL	and	predominantly	just	replicating	the	major	arc,	hence	the	specific	stall	in	the	2D	gels.	The	unusual	slope	in	sequencing	reads	 from	the	heart	 indicates	replication	being	 initiated	 faster	 than	 it	can	be	completed,	giving	more	reads	closer	to	the	origin,	hence	the	generalized	stalling	in	the	2D	gel	experiments.		There	are	many	studies	suggesting	that	mtDNA	mutations	play	 important	role	in	 the	 ageing	 process.	 Some	 ageing	 cell	 types	 accumulate	 point	mutations	 and	 other	mtDNA	 deletions128.	 It	 has	 been	 reported	 that	 single	 large	 mtDNA	 deletions	accumulated	above	threshold	 levels	of	>60%	can	cause	respiratory	chain	dysfunction	due	to	removal	of	one	or	more	tRNA	genes	152.	Low	level	of	mtDNA	deletions	were	also	
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detected	 in	brain	and	heart	of	adult	ageing	humans153.	Furthermore,	 it	has	been	also	demonstrated	 that	 COX	 deficient	 muscle	 fibers	 in	 elderly	 humans	 have	 clonal	accumulation	of	mtDNA	deletions154.	Moreover	mosaic	respiratory	chain	deficiency	has	been	described	in	many	tissues	in	ageing	humans	(heart,	skeletal	muscle,	dopaminergic	neurons,	colon)	due	to	clonally	expanded	single	large	mtDNA	deletions154,155,156,	157.	The	mtDNA	 mutator	 mouse	 is	 a	 very	 important	 mouse	 model	 to	 study	 somatic	 mtDNA	mutations	 and	 ageing.	 Those	mice	 develop	 progressive	 premature	 ageing	 syndrome	phenotypes	including	cardiomyopathy,	reduced	fertility,	weight	loss,	kyphosis,	anemia,	hair	 loss,	 alopecia,	 hearing	 loss,	 and	 osteoporosis56.	Mutator	mice	 have	 an	 increased	number	of	point	mutations	due	to	a	proofreading	deficiency	of	the	mitochondrial	DNA	polymerase.		As	described	above	in	addition	to	point	mutations,	they	also	have	a	large	linear	around	11kb	deletion,	similar	to	our	Mgme1	knockout	mouse	model	(Figure	4.1).	Some	reports	have	suggested	that	high	levels	of	these	linear	molecules	may	cause	the	progeroid	phenotype	of	 the	mtDNA	mutator	mouse158,159.	As	mentioned	 earlier,	 now	we	know	that	a	truncated	liner	fragment	is	a	direct	consequence	of	a	failed	ligation	of	the	nascent	H-strand	at	OH84.	The	 fact	 that	Mgme1	knockout	mice	have	similar	 linear	deletion	as	found	in	mutator	mice	and	do	not	display	any	premature	ageing	phonotype,	suggests	that	progeroid	phenotype	is	not	caused	by	mtDNA	linear	deletions.		
 Similarly	 to	 human	 patient	 fibroblasts	 carrying	 nonsense	 mutations	 in	 the	
Mgme1	gene,	we	report	that	loss	of	MGME1	in	mice	leads	to	an	increase	in	the	steady-state	7S	DNA	 levels.	Our	 results	 also	 confirmed	 the	 existence	of	 extended	5’	7S	DNA	ends	 in	Mgme1	knockout	mouse	mitochondria.	 Although	DNA	molecules	with	 longer	5`ends	are	also	 found	 in	control	mice,	 they	were	more	abundant	 in	Mgme1	knockout	animals.	Surprisingly,	especially	given	 the	 increased	steady	state	 levels	of	7S	DNA,	 in	isolated	 MGME1	 knockout	 mitochondria	 the	 de	 novo	 synthesis	 of	 7S	 DNA	 was	completely	abolished	as	 judged	by	the	 in	organello	 replication	experiment.	Under	the	same	experimental	 conditions,	 synthesis	of	whole	mtDNA	molecule	was	only	 slightly	decreased.	This	striking	discrepancy	between	lack	of	de	novo	synthesis	and	increased	steady-state	 7S	 DNA	 levels	 is	 a	 likely	 consequence	 of	 increased	 stability	 of	 those	molecules	in	absence	of	MGME1	nuclease	activity.		The	 reduction	of	 7S	 synthesis	 in	 favor	 of	 full-length	mtDNA	 replication	 in	 the	
Mgme1	 knockout	 mice	 suggests	 that	 MGME1	 could	 regulate	 mtDNA	 replication	 and	potentially	 may	 determine	 productivity	 of	 replication.	 This	 MGME1	 action	 is	 likely	
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indirect	 as	 this	 nuclease	was	 shown	 to	 lack	 direct	 DNA	 binding	 activity160.	 Previous	studies	 and	 analysis	 of	 displacement	 loop	 (D-loop)	 region	 sequences	 from	 different	mammalian	 orders	 also	 have	 identified	 transcription	 termination	 events	 in	 this	region161.	 Consistently,	 in	 Mgme1	 knockout	 model	 we	 detected	 a	 lack	 of	 HSP	transcription	 termination	 and	 accumulation	 of	 ACR	 over	 the	 D-loop	 region.	 An	 ACR	transcript	has	been	previously	described	to	form	in	response	to	thiamphenicol	(TAP)	treatment	 in	 cell	 culture162.	 In	 the	 mammalian	 system,	 the	 presence	 of	 an	 ACR	transcript	 has	 been	 found	 in	 mice	 whose	 heart	 Tfam	 was	 disrupted,	 but	 which	expressed	the	hTFAM	protein	instead.	Interestingly,	in	those	rescue	mice	the	levels	of	7S	DNA	were	significantly	reduced.		Mgme1	 knockout	 mice	 display	 altered	 steady-state	 levels	 of	 mitochondrial	transcripts.	 Transcripts	 originating	 from	 HSP	 promoter	 appear	 reduced	 while	promoter	 proximal	 transcripts	 from	 LSP	 in	Mgme1	knockout	mice	 appear	 increased	and	promoter	 distal	 transcripts	 unaltered.	 The	possible	 reason	 for	 this	 phenomenon	could	be	 the	ACR	 transcript’s	 interference	with	 the	H-strand	 transcription	promoter.	As	 a	 consequence	 of	 decreased	 HSP	 transcription	 initiation,	 the	 transcription	machinery	would	be	available	and	would	shift	to	the	LSP	promoter	thereby	resulting	in	an	increased	transcription	initiation	from	the	LSP	promoter	and	increased	levels	of	LSP	promoter	proximal	transcripts.		
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Interestingly	we	observed	decreased	levels	of	7S	RNA	in	Mgme1	knockout	mice	despite	boosted	L-strand	promoter	proximal	transcription.	7S	RNA	was	shown	to	serve	as	a	primer	for	leading	strand	replication	at	OH163.	When	not	priming	replication	these	transcripts	 can	 be	 terminated	 at	 CSB1	 and	 polyadenylated.	 The	 exact	 function	 and	termination	of	7S	RNA	at	CSB1	remains	unclear.		
	
Figure 4.2: The termination complex at the end of D-loop region. Upper panel: replication is 
terminated in presence of MGME1 and TAS protein producing 7S DNA. The same complex 
terminates HSP transcription. Lower panel: Model to show full-length mtDNA production and HSP 
transcription over the D-loop region in absence of MGME1 protein due to termination complex 
destabilization or loosening.  
 We	suggest	that	most	LSP	initiation	events	are	used	up	for	DNA	synthesis	and		mtDNA	 transcription	 resulting	 in	 the	 absence	 of	 longer	 polyadenylated	 7S	 RNA	 in	
Mgme1	knockout	mice.	According	to	the	most	commonly	accepted	mechanism,	7S	RNA	is	synthesized	by	transcription	from	LSP110	and	our	results	would	suggest	that	both	-	transcription	 at	 LSP	 and	 thereby	 replication	 at	 OH	 	 -	 are	 increased.	 This	 replication	
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initiation	 boost	 at	 OH	 is	 also	 evident	 from	 our	 sequence	 coverage	 reads	 in	 D-loop	region.	Additionally	we	detected	upregulation	of	LSP	proximal	promoter	transcripts	in	
Mgme1	knockout	mice.	The	 observed	 tissue-specificity	 of	 our	 Mgme1	 knockout	 mouse	 model	 is	 in	accord	with	 the	well-known	 tissue	 heterogeneity	 of	mitochondrial	 disorders130.	 This	tissue-specificity	may	be	linked	to	the	observation	that	different	tissues	have	different	energy	 demands	 and	 biosynthetic	 capacities.	 For	 instance,	 brain	 mitochondria	 can	oxidize	 ketones,	 whereas	 skeletal-muscle	 mitochondria	 are	 particularly	 efficient	 in	oxidizing	 fatty	 acids.	 In	 the	 liver,	 a	wide	 range	 of	 unique	 biochemical	 reactions	 take	place	 that	 aim	 at	 the	 metabolism	 and	 synthesis	 of	 diverse	 molecules,	 and	 include	xenobiotic	 detoxification,	 protein	 synthesis,	 transmethylation	 and	 transulfation	reactions,	and	 the	processing	of	various	other	metabolites129.	Therefore	 it	 is	possible	that	the	mitochondrial	function	and	energy	homeostasis	process	in	the	liver	is	subject	to	unique	cues,	and	this	may	contribute	to	the	distinct	molecular	phenotype	observed	in	the	livers	or	our	Mgme1	knockout	mice.	All	 the	 observed	 changes	 in	 mitochondrial	 protein	 and	 respiratory	 chain	complexes	 levels	 in	 Mgme1	 homozygous	 knockout	 mice	 support	 the	 proposed	regulatory	role	of	MGME1	protein	in	mtDNA	replication.			Therefore,	we	hypothesize	that	MGME1	could	regulate	processes	at	 the	end	of	the	 control	 region	 to	 arrest	 replication	 and	 H-strand	 synthesis	 (Figure	 4.2	 upper	panel).	In	the	absence	of	MGME1,	the	termination	complex	at	the	end	of	D-loop	region	will	be	disengaged	and	replication	and	transcription	machineries	will	proceed	pass	this	site.	 (Figure	 4.2	 lower	 panel).	 In	 support	 of	 our	 model,	 both	 DNA	 replication	 and	transcription	 termination	 events	 at	 this	 site	 are	 diminished	 when	 mtDNA	 synthesis	needs	to	recover	after	depletion	(block	is	released)111.		In	 order	 to	 further	 investigate	 regulatory	 role	 of	 TWINKLE	 and	 MGME1	 in	mtDNA	 replication	 we	 aim	 to	 identify	 their	 interaction	 partners	 with	 a	 particular	interest	in	discovering	potential	TAS	interacting	replication	regulators.	In	a	search	for	interaction	proteins	we	will	 employ	Co-IP,	 proximity-dependent	biotin	 identification,	(BioID)165	and	DNA	Electrophoretic	Mobility	Shift	Assay	(EMSA)	methods	.	
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5.	METHODS		
Generation	of	MGME1	knockout	mice			 To	 generate	 conditional	 knockout	Mgme1	mice,	 exons	 III	was	 flanked	by	 loxP	sites.	 The	 puromycin	 resistance	 cassette	 was	 introduced	 as	 a	 selection	 marker	 and	removed	 by	 mating	 of	 Mgme1+/loxP-pur	 mice	 with	 transgenic	 mice	 ubiquitously	expressing	 Flp-recombinase.	 Mgme1+/loxP	 mice	 were	 mated	 with	 mice	 ubiquitously	expressing	cre	recombinase	to	generate	heterozygous	knockout	Mgme1+/-	mice	(Figure	4A)	 Further	 to	 obtain	 tissue	 specific	 (heart	 and	 skeletal	 muscle)	 mice104,166-168,		
Mgme1	knockout	mice	we	crossed	Mgme1	loxP/loxP	mice	with	transgenic	mice	expressing	cre-recombinase	under	the	control	of	the	muscle	creatinine	kinase	promoter	(Ckmm-cre).	 Double	 heterozygous	 mice	 (Mgme1+/loxP,	 +/Ckmm-cre)	 were	 mated	 to	 homozygous	
Mgme1	loxP/loxP	mice	to	generate	tissue-specific	knockout	(Mgme1	 loxP/	loxP,	+/Ckmm-cre)	and	control	(Mgme1	loxP/loxP)	mice.		
Generation	of	BAC	and	BAC	FLAG	TWINKLE	transgenic	mice			 Clone	 Finder	 of	 the	 National	 Center	 for	 Biotechnology	 Information	 (NCBI)	database	was	used	to	 identify	a	BAC	clone	containing	Twinkle.	The	clone	was	218	kb	long,	with	two	flanking	sequences	upstream	and	downstream	of	Twinkle	(95	and	67	kb	respectively)	 and	 it	 was	 obtained	 from	 Children’s	 Hospital	 Oakland-BAC-PAC	Resources.	 The	 BAC	 was	 modified	 by	 ET	 recombination	 to	 allow	 discrimination	between	transcripts	expressed	from	the	endogenous	Twinkle	gene	and	the	introduced	BAC	 clone.	 Alteration	 of	 the	 coding	 sequence	 created	 a	 synonymous	 change	 to	introduce	 a	XhoI	restriction	 enzyme	 site	 in	 exon	 1,	 allowing	 the	 distinction	 between	transcripts	 expressed	 from	 the	 endogenous	 Twinkle	 gene	 and	 the	 introduced	 BAC	clones.				
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Southern	blot	analysis		 Genomic	 DNA	 from	 tissues	 of	Mgme1	 mice	 was	 isolated	 by	 Gentra	 Puregene	Tissue	Kit	and	extraction	was	performed	as	 instructed	in	the	kit.	A	total	of	2	μg	from	heart,	 brain,	 kidney	 and	 skeletal	 muscle	 tissue	 were	 digested	 with	 the	 restriction	enzyme	SacI,	XhoI	or	SphI,	and	then	separated	DNA	molecules	by	electrophoresis	on	a	0.8%	 Agarose	 gel.	 Wet	 transfer	 was	 completed	 in	 20xSSC	 (150mM	 NaCl,	 15mM	Na3CitrateX2H2O)	 overnight	 on	 a	 nylon	 membrane	 (Amersham	 HybondTM-N+).	Probes	were	labeled	with	32P-dCTP	and	hybridization	was	performed	for	detection	of	total	mtDNA,	D-loop	(7S	DNA)	or	nuclear	DNA	(18S	rDNA).	For	 the	D-loop,	Southern	samples	were	heated	for	3	min	at	93C	prior	loading.				
De	novo	DNA	synthesis			 Heart	mitochondria	(1	mg)	was	resuspended	in	0.5	ml	of	incubation	buffer	(25	mM	 sucrose,	 75	 mM	 sorbitol,	 100	 mM	 KCl,	 10	 mM	 K2HPO4,	 0.05	 mM	 EDTA,	 5	 mM	MgCl2,	 1	mM	ADP,	 10	mM	 glutamate,	 2.5	mM	malate,	 10	mM	 Tris–HCl,	 pH	7.4)	 also	containing	 1	mg/ml	 fatty	 acid-free	 bovine	 serum	 albumin	 (BSA),	 50	 µM	 each	 dTTP,	dCTP	and	dGTP	and	20	µCi	[α-32P]dATP	(3000	Ci/mmol).	Incubation	was	carried	out	at	37°C	 for	 2h	 on	 a	 rotating	 wheel.	 For	 pulse–chase	 experiments,	 mitochondria	 were	incubated	with	[α-32P]dATP	(final	concentration	5	µM)	for	2h,	followed	by	a	chase	with	non-radiolabeled	 dATP	 (5	mM)	 and	 further	 incubation	 for	 1h	 .	 After	 incubation,	mitochondria	 were	 pelleted	 at	 9000rpm	 for	 4	 min	 and	 washed	 twice	 with	 10%	glycerol,	10	mM	Tris–HCl,	pH	6.8,	0.15	mM	MgCl2.	The	pellet	was	then	resuspended	in	300	µl	of	Lysis	buffer	and	DNA	was	isolated	by	Gentra	Puregene	Tissue	Kit	(QIAGEN)	and	extraction	was	performed	as	 instructed	in	 the	 kit.	 After	 precipitation	 and	 centrifugation,	 the	 pelleted	 nucleic	 acids	 were	dissolved	in	25mM	EDTA.	Pellet	was	dissolved	on	55°C	for	1h	and	treated	with	RNase	A	for	15	min,	37°C.	
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Before	 loading	 samples	were	heated	at	93°C	 for	5	min	 to	 release	7S	DNA	and	analyzed	by	1%	agarose	gel	electrophoresis.	After	the	run,	wet	transfer	was	completed	in	 20xSSC	 (150mM	NaCl,	 15mM	Na3CitrateX2H2O)	 overnight	 on	 a	 nylon	membrane	(Amersham	HybondTM-N+).			
Northern	blot	analysis		 RNA	isolation	from	mouse	heart	tissues	was	done	using		RNeasy	Mini	Kit	and	a	fast	 prep	 machine	 with	 2x30	 sec	 pulses	 at	 speed	 6.	 Following	 RNA	 isolation,	procedures	were	performed	as	 instructed	 in	 the	kit	 (RNeasy	Mini	Kit,	QIAGEN).	RNA	concentration	was	 detected	 on	 a	 Spectrophotometer	 (NanoDrop	 2000c,	 Peqlab)	 and	2μg	of	total	RNA	was	separated	on	a	1.2%	agarose	gels	containing	formaldehyde	and	transferred	to	nylon	membranes	(Amersham	HybondTM-N+).		
	
	
De	novo	Transcription	Assay		 Isolated	 mitochondria	 (2	 mg)	 from	 heart	 were	 resuspended	 in	 500	 μl	 of	transcription	buffer	containing	25	mM	sucrose,	75	mM	sorbitol,	100	mM	KCl,	10	mM	K2HPO4,	50	mM	EDTA,	5	mM	MgCl2,	1	mM	ADP,	10	mM	glutamate,	2.5	mM	malate,	and	10	 mM	 Tris-HCl	 (pH	 7.4)	 with	 1	 mg	 of	 BSA/ml.	 The	 mitochondrial	 suspension	containing	50	μCi	of	[α-32P]UTP	(Amersham	Biosciences)	was	incubated	by	rotating	the	mixture	 for	 40	 h	 at	 37	 °C.	 After	 the	 incubation,	 the	mitochondria	were	 pelleted	 and	washed	twice	with	resuspension	buffer	containing	10%	glycerol,	10	mM	Tris-HCl	(pH	6.8),	 and	0.15	mM	MgCl2.	Mitochondrial	RNA	was	 isolated	 from	the	 final	pellet	using	the	Trizol	and	chloroform,	and	resuspended	in	10	μl	of	nuclease	free	water.		After	adding	Sigma	RNA	leading	buffer	samples	were	separated	in	1.2%	agarose	gel	containing	formaldehyde	at	120	V	for	2	h.				
Quantitative	PCR		 Total	RNA	from	mouse	heart	was	extracted	using	the	RNeasy	Mini	Kit,	QIAGEN	kit.	 Reverse	 transcription	 and	 quantitative	 RT-PCR	 were	 performed	 using	 the	 High	Capacity	 RNA-to-cDNA	 kit	 (Applied	 Biosystems)	 and	 TaqMan®	 2×	 Universal	 PCR	Master	Mix,	No	AmpErase®	UNG	(Applied	Biosystems).	The	following	TaqMan	probes	
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against	 mouse	 mitochondrial	 transcripts	 were	 obtained	 from	 Applied	 Biosystems:	TFAM,	POLRMT,	PGC1α,	TWINKLE,	COX1,	POLG,	DNA2,	EXOG,	MGME1,	FEN1	and	COXI.	18	S	rRNA	was	used	as	a	probe	to	detect	this	nuclear	transcript.		
Western	Blot	analysis		 20	 μg	 of	 isolated	 mitochondria	 (obtained	 by	 differential	 centrifugation	 as	previously	 described104)	 from	 heart	 and	 liver	 tissue	 were	 resuspended	 in	 SDS	 4X	Lämmli-Buffer	 (4%	 SDS,	 20%	 Glycerol,	 120mM	 Tris,	 0,02%	 Bromophenol	 Blue).	Proteins	 were	 separated	 on	 in	 4-12%	 NuPage	 gels	 (Invitrogen)	 and	 transferred	 on	HyboundTM-P	membrane	(GE	Helthcare).	Rabbit	polyclonal	antisera	were	used	to	detect	POLRMT,	EXOG,	HSP60,	COX	II,	TFAM	 and	 TWINKLE.	 MitoProfile	 total	 OXPHOS	 antibody	 cocktail	 (MitoSciences,	1:1000),	was	used	for	analysis	of	mitochondrial	respiratory	chain	complexes.		
Long-extension	PCR			 Using	 2	 ng	 of	 total	 DNA	 mtDNA	 was	 amplified	 from	 Mgme1	 knockout	 and	control	 with	 the	 primers	 using	 P1	 and	 P2	 primers	 (P1:cctactagcaattatcccca,	P2:catagtggggtatctaatcccag)	using	LA	Taq	polymerase	(TAKARA),	Japan	
	
Phenol	chloroform	extraction			 A	small	piece	of	mouse	tissue	from	heart,	liver,	brain,	kidney,	muscle	or	tail	was	incubated	in	400	μl	lysis	solution	(0.5%	SDS,	0.1	M	NaCl,	50mM	Tris-HCl,	pH8.0,	2.4mM	EDTA)	supplied	with	8μl	proteinase	K	(10mg/ml)	shaking	at	55°C	for	2-3	hrs,	until	the	tissue	 was	 completely	 dissolved.	 Next,	 75	 μl	 of	 8M	 potassium	 acetate	 and	 0.5ml	chloroform	 were	 added	 and	 the	 samples	 were	 vortexed	 for	 10	 sec.	 followed	 by	incubation	 at	 -	 80	 °C	 for	 at	 least	 30min	 or	 o/n.	 Phase	 separation	 was	 achieved	 by	centrifugation	 at	maximum	 speed	 in	 a	 bench	 top	 centrifuge	 (Eppendorf).	 The	 upper	(aqueous)	phase	was	transferred	to	a	new	eppendorf	tube	and	1	ml	99%	ethanol	was	added	 to	 each	 sample	 to	 precipitate	 the	 DNA.	 Tubes	were	 inverted	 several	 times	 at	room	 temperature	 and	 centrifuged	 at	 maximum	 speed	 in	 a	 benchtop	 centrifuge	 for	10min	at	RT.	Pellets	were	rinsed	with	0.5	ml	75%	ethanol	and	spinned	for	another	5	
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min	at	max	speed.	All	residual	ethanol	was	removed	and	the	pellet	was	dissolved	in	an	appropriate	amount	of	dH2O.	For	long	term	storage	samples	were	stored	at	-	20°C.		
	
DNA	extraction	with	Puregene®	Core	Kit	A	(Qiagen)			 A	small	piece	of	 frozen	tissue	from	mouse	brain,	heart,	 liver,	kidney	or	muscle	was	grinded	with	mortar	and	pestle	in	liquid	nitrogen.	The	frozen	tissue	powder	was	transferred	 into	 a	 new	 eppendorf	 tube	 and	 mixed	 with	 300μl	 Cell	 lysis	 solution	(Qiagen).	DNA	was	extracted	as	recommended	by	the	manufacturer	and	kept	at	+4°C	for	short	term	and	-20°C	for	long	term	storage.		
	
RNA	isolation	with	ToTALLY	RNA	TM	kit	(Ambion)			 A	small	piece	of	fresh	or	frozen	tissue	from	mouse	brain,	heart,	liver,	kidney	or	muscle	was	extracted	with	Lysing	Matrix	D	tubes	from	MP	Bio	and	ToTALLY	RNATM	kit	 from	 Ambion	 by	 following	manufacturers	 instructions.	 The	 final	 RNA	 pellet	 was	dissolved	in	an	appropriate	amount	of	DEPC	treated	water	at	50°C	for	15	min.	RNA	was	stored	at	-80°C.		
	
DNA/RNA	quantification	with	Qubit®	1.0	fluorometer	(Invitrogen)			 DNA	quantification	with	the	Qubit®	1.0	fluorometer	is	based	on	intercalation	of	the	reagent	in	double	stranded	DNA.	For	standard	preparation	190μl	working	solution	(Invitrogen)	and	10μl	Standard	(Invitrogen)	were	vortexed	and	incubated	at	RT	for	2	min.	 Sample	 preparation	was	 performed	 by	mixing	 198μl	working	 solution	with	 2μl	DNA	 sample,	 vortexing	 and	 incubation	 at	RT	 for	 2	min.	 In	 the	 following,	 tubes	were	analysed	 in	 the	 Qubit®	 fluorometer	 (Invitrogen)	 according	 to	 the	 manufactorers	instructions.		
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DNA	agarose	gelelectrophoresis			 For	 separation	 of	 DNA	 fragments,	 DNA	 samples	 were	 run	 on	 a	 0.8%-1.8	 %	agarose	 gel,	 depending	 on	 size	 and	number	 of	 the	DNA	 fragments.	 0.8-1.8	 g	 agarose	were	mixed	 with	 100ml	 0.5	 x	 TBE	 buffer	 (90mM	 Tris-Base,	 90mM	 H3BO3,	 2.5	 mM	EDTA)	and	cooked	in	a	microwave	until	 the	agarose	got	dissolved	completely.	Before	the	melted	agarose	was	poured	into	a	gel	chamber,	few	microliter	of	ethidium	bromide	were	added.	After	the	gel	was	polymerized,	DNA	samples	were	loaded	and	run	at	135	–	150	V.	The	gel	was	analysed	in	an	UV	imaging	system	(Syngene	u:Genius).		
	
Reverse	transcription			 1-2μg	 of	 DNase	 treated	 RNA	 (see	 section	 2.4.7)	was	 dissolved	 in	DEPC-water	with	 a	 final	 volume	 of	 10μl.	 Another	 10μl	 of	 a	 reverse	 transcription	 mastermix	containing	10	x	RT	buffer,		25	x	dNTP	mix,	10x	random	primers,	reverse	transcriptase,	RNase	inhibitor	and	nuclease-free	 H2O	 as	 recommended	 in	 the	 manufactorers	 instructions	 of	 the	 High	capacity	 cDNA	 Reverse	 Transcription	 Kit	 (Applied	 Biosystems)	 RT	 reaction	 was	performed	 in	 a	 thermocycler	 (Applied	 Biosystems)	 as	 recommended	 in	 the	manufactorers	instructions.	cDNA	was	stored	at	-20°C.		
	
Isolation	of	mitochondria	from	mouse	tissue			 Dissected	 heart,	 brain,	 muscle,	 liver	 or	 kidney	 from	mouse	was	washed	with	mito	 isolation	 buffer,	 followed	 by	 homogenization	 on	 ice	 with	 a	 glass-teflon	homogenizer	 (Sartorius,	 Potter	 S)	 in	 10	ml	 (liver	 in	 13	ml)	mito	 isolation	 buffer	 1X	complete	 protease	 inhibitor	 cocktail	 (Roche)	 at	 600rpm	 with	 20	 strokes.	 Next,	 the	lysate	was	centrifuged	for	10	min,	at	1000xg,	4°C.	The	supernatant	was	transferred	in	a	fresh,	pre-cooled	falcon	tube	and	spinned	for	10	min	at	12.000	x	g,	4°C.	Mitochondria	were	washed	with	mito	isolation	buffer	three	times	for	5	min	at	12.000	x	g,	4°C,	before	the	 pellet	 was	 resuspended	 in	 an	 appropriate	 volume	 of	 mito	 isolation	 buffer.	 For	storage,	mitochondria	were	frozen	in	liquid	nitrogen	and	put	into	-80°C.		
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Blue	Native	PAGE			 To	study	the	assembly	of	respiratory	chain	complexes	Blue	Native	gel	analyses	was	performed.	Twenty	μg	of	 isolated	mitochondria	were	pelleted	and	solubilized	 in	cold	 1	 x	 NativePAGE	 Sample	 buffer	 (Invitrogen)	 containing	 1%	DDM.	 Proteins	were	incubated	at	4°C	for	15	min	and	pelleted	at	20.000	x	g	for	30	min,	4°C.	The	supernatant	was	 loaded	 on	NativePAGETMNovex®Bis-Tris	 gel	 and	 run	 at	 150V	 for	 60	min	using	NativePAGETM	Running	buffer	and	NativePAGETM	Cathode	buffer	as	described	in	the	manufactorers	instructions.	Later	voltage	was	increased	to	250	V	for	the	remainder	of	the	run.	For	blotting	procedure	see	western	blot	section.			
Probe	labelling	with	[α−32P]	dCTP	using	Prime-It®	II	Random	Primer	Labeling	
Kit	(Agilent)			 50	 –	 80	 ng	 template	 DNA	 (1μl)	 were	 mixed	 with	 10μl	 Random	 Primer	 Mix	(Agilent)	 and	23μl	dH2O.	 reaction	was	heated	 for	5	min	at	100°C,	before	addition	of	10μl	 of	 5	 ×	 dCTP	 primer	 buffer,	 1μl	 Exo(–)	 Klenow	 enzyme	 (5	 U/μl)	 and	 5μl	[α−32P]dCTP	 at	 3000	 Ci/mmol	 (Perkin	 Elmer).	 Next,	 the	 reaction	 was	 incubated	 at	37°C	 for	30	min,	 to	allow	radioactive	 labelling	of	 the	oligonucleotides.	Purification	of	the	 radiolabeled	 probe	 was	 performed	 in	 an	 illustra	 MicroSpin	 G-50	 column	 (GE	Healthcare)	 at	 3000rpm	 for	 2min.	 In	 the	 final	 step	 the	 radioactive	 oligonucleotides	were	cooked	at	100°C	 for	5min,	 to	melt	 the	double	 strands.	 If	not	used	 immediately,	probes	were	stored	at	-20°C.			
Oligonucleotide	labelling	with	[γ−32P]	ATP	using	T4-polynucleotide	kinase	
		 50	 –	 80	 ng	 template	 DNA	 (1μl)	 were	 mixed	 with	 12μl	 dH2O,	 2μl	 of	 10	 x	polynucleotide	kinase	buffer	(NEB),	1μl	T4	polynucleotide	kinase	and	4μl	[γ−32P]	ATP	at	 3000	 Ci/mmo	 (Perkin	 Elmer).	 The	 reaction	 was	 heated	 at	 37°C	 for	 45	 min,	 and	subsequently	 purified	 in	 an	 illustra	 MicroSpin	 G-25	 column	 (GE	 Healthcare)	 at	3000rpm	for	2min.	If	not	used	immediately,	probes	were	stored	at	-20°C.		
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ACR	transcript	labeling	using	Riboprobe	System	T7	Kit	(Promega)			 2,5μg	pCR-II-TOPO-	D-loop	plasmid	was	digested	with	HindIII	 at	37°C,	o/n.	 In	the	following,	plasmid	was	purified	using	PCR	purification	kit	(QIAGEN).	Subsequently,	the	 DNA	 was	 used	 as	 template	 for	 the	 Riboprobe	 in	 vitro	 transcription	 system	(Promega).	 A	 transcription	 reaction	 containing	 of	 rNTPs,	 DTT,	 transcription	 buffer,	RNasin	 ribonuclease	 inhibitor,	 linearized	 DNA	 template,	 [α-32P]	 rCTP	 (50μCi	 at	10μCi/μl)	 and	T7	polymerase	was	pipetted	 following	 the	manufactorers	 instructions	and	 incubated	 at	 37°C	 for	 2hrs.	 After	 addition	 of	DNase	 I	 and	 another	 incubation	 at	37°C	 for	 15min,	 the	 probe	was	 purified	 using	 a	 illustra	MicroSpin	 G-50	 column	 (GE	Healthcare).	If	not	used	immediately,	probes	were	stored	at	-20°C.		
	
Preparation	of	purified	mitochondria	from	different	tissue	and	mitochondrial	
DNA		 Mitochondria	 from	 the	 brain	 were	 isolate	 following	 protocol	 from	 Milenyi	Biotec	 mitochondrial	 extraction	 tissue	 kit	 using	 TOM22	 MicroBeads.	 Briefly,	 whole	brains	 were	 treated	 with	 extraction	 buffer,	 homogenized	 using	 the	 gentleMACS	Dissociator.	 Homogenate	 was	 filtrated	 and	 mitochondria	 were	 labeled	 with	 Anti-TOM22	mouse	MicroBead.	Magnetically	labeled	material	was	applied	on	a	MACS	Colum	in	a	MACS	Separator.	Finally	column	is	removed	and	intact	mitochondria	were	eluted.		Mitochondria	from	liver	and	heart	was	isolated	according	to	standard	protocol	where	all	liver	and	hearts	were	homogenized	under	ice-cold	conditions	and	cell	debris	pelleted	by	 low	speed	centrifugation	 (1000	g,	4uC	 for	 ten	minutes).	The	 supernatant	was	 transferred	 and	 the	mitochondria	 pelleted	 by	 centrifugation	 at	 100000	 g	 for	 10	min.	Resuspended	mitochondria	were	isolated	by	centrifugation	in	a	1.0M/1.5M	two-phase	sucrose	gradient.		mtDNA	 from	 all	 tissues	 was	 isolated	 by	 Gentra	 Puregene	 Tissue	 Kit	 and	extraction	was	 performed	 as	 instructed	 in	 the	 kit.	 The	DNA	was	 treated	with	RNase	prior	to	use.		
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Northern	Blotting	using	biotinylated	probes		 RNA	 was	 isolated	 from	 hearts	 using	 the	 miRNeasy	 Mini	 kit	 (QIAGEN)	incorporating	an	on-column	RNase-free	DNase	digestion	to	remove	all	DNA.	RNA	(5	μg)	was	 resolved	 on	 1.2%	 agarose	 formaldehyde	 gels	 and	 then	 transferred	 to	 0.45	μm	Hybond-N+	 nitrocellulose	 membrane	 (GE	 Healthcare	 Life	 Sciences)	 and	 hybridized	with	 biotinylated	 oligonucleotide	 probes	 specific	 to	 mouse	 mitochondrial	 mRNAs,	rRNAs,	 and	 tRNAs.	 Hybridizations	 were	 carried	 out	 overnight	 at	 50°C	 in	 5×	 saline	sodium	citrate	(SSC),	20	mM	Na2HPO4,	7%	SDS,	and	100	μg	×	ml–1	heparin,	followed	by	washing.	 The	 signal	 was	 detected	 using	 either	 streptavidin-linked	 horseradish	peroxidase	or	streptavidin-linked	infrared-labeled	antibody	(diluted	1:2,000	in	3×	SSC,	5%	 SDS,	 25	mM	Na2HPO4	 [pH	 7.5])	 by	 enhanced	 chemiluminescence	 (GE	Healthcare	Life	Sciences)	or	using	an	Odyssey	Infrared	Imaging	System	(Li-COR	Biosciences).	
Sequencing	library	preparation	and	pair-end	DNA	sequencing			 mtDNA	Quality	 control	was	done	using	 the	Agilent	TapeStation	Genomic	DNA	ScreenTape	 and	 the	 Qubit	 BR	 kit.	 The	 library	 preparation	 protocol/kit	 was	 the	NEBNext	Ultra™	DNA	Library	Prep	Kit	for	Illumina	(NEB)	after	fragmentation	of	150	ng	gDNA	with	 the	Covaris	 to	 the	 requested	 insert	 size	of	>	500	bp.	The	 sequencing	 run	conditions	were	2x250	bp	on	the	Illumina	HiSeq2500,	using	HiSeq	Rapid	v2	Kits	from	Illumina.	Each	 library	 was	 indexed	 individually	 with	 the	 provided	 barcodes	 and	sequenced	to	6	000	000	reads	(tolerance	range	-	30	%)	The	reads	were	aligned	to	the	C57Bl/6J	 mouse	 mtDNA	 reference	 sequence	 (NC_005089.1),	 using	 the	 corona	 lite	mapping	algorithm	(Applied	Biosystems)	with	default	settings.	The	first	49	bases	of	the	mtDNA	sequence	were	appended	to	the	end	of	the	reference	to	avoid	that	reads	fail	to	align	 due	 to	 the	 circularity	 of	 the	 mitochondrial	 genome.	 This	 alignment	 procedure	attempts	to	map	each	read	at	full	length	to	the	reference	sequence,	allowing	for	at	most	6	mismatches	for	each	50	bp	read.					
			 85	
Two-Dimensional	(2D)	Agarose	Gel	Electrophoresis			 For	 two-dimensional	 gels,	 mtDNA	 was	 isolated	 from	 fresh	 sucrose	 purified	mitochondria	 from	 liver	 and	 heart	 tissue	 and	 the	 by	 sequential	 phenol-chloroform	extraction	 according	 to	 established	 protocols39.	 Resulting	 DNA	 (10–20	 μg)	 was	digested	 BclI	 and	 separated	 on	 agarose	 gels	 with	 according	 to	 the	 manufacturer's	instructions	 (NEB)	 and	 to	 protocols	 described	 in	 detail.	 Gels	 were	 then	 blotted,	hybridized	 with	 two	 different	 probes:	 OH-containing	 fragment	 and	 OL-containing	fragment.	Membranes	were	washed	with	1×	SSC	three	times	for	20	min	and	then	with	1×	SSC	with	0.1%	SDS	three	times	for	20	min.	The	primer	sequences	used	to	produce	the	probes	are:		
Cell	culture	and	ddC	treatment				 Mouse	embryonic	fibroblast	were	grown	at	37°C,	5%	CO2	and	95%	humidity	in	10cm	 dishes	 supplied	with	 10ml	 Dulbecco's	Modified	 Eagle	Medium	 (DMEM;	 Gibco)	containing	 10%	 Fetal	 Bovine	 Serum	 and	 penicilline	 (100μg/ml	 /streptomycine	(100μg/ml).	ddC	(Sigma)	100mM	stock	solution	was	used	at	a	final	concentration	of	20	µM.	Cells	were	 treated	 for	3	days	 and	 afterwards	 resuspended	 in	 fresh	medium	at	 a	concentration	 of	 1.5–2	 ×	 105	 cells/ml.	 A	 subsequent	 complete	medium	 replacement	without	ddC	allowed	recovery	of	mtDNA.	Total	DNA	was	isolated	by	Gentra	Puregene	Tissue	Kit	and	extraction	was	performed	as	instructed	in	the	kit.		
	
Material			 Used	 chemicals	 were	 ordered	 from	 Ambion,	 Invitrogen,	 Qiagen,	 AppliChem,	Fisher	Scientific,	Fluka,	Roth,	and	Sigma	Aldrich.	Enzymes	and	their	according	buffers	were	 delivered	 from	 New	 England	 Biolabs.	 Transfer	 of	 nucleic	 acids	 was	 done	 on	Amersham	Hybond-N+	nylon	(GE	Healthcare)	membranes	 from.	Protein	 transfer	was	performed	on	Hybond-	C	extra	(GE	Healthcare)	nitrocellulose	membranes	or	Hybond-P	PVDF	(GE	Healthcare)	membranes.	Radioactivity	(32P)	to	label	nucleic	acids	was	used	from	 Perkin	 Elmer.	 Autoradiography	 was	 performed	 by	 using	 Amersham	 Hyperfilm	MP	(GE	Healthcare)	and	ECL	solutions	were	bought	 from	Biorad.	Protein	samples	for	
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Western	Blots	were	loaded	on	Invitrogen	or	Criterion	gels	from	Biorad.	For	Blue	Native	PAGE	experiments	Invitrogen	gels	were	used.			The	following	primary	antibodies	were	used:			MitoProfile	total	oxidative	phosphorylation	mixture											Mitosciences		ExoG	 Proteintech		HSP	60	 Cell	signaling	COX1		 Invitrogen	MTERF1	 Proteintech		TFAM	 Abnova	POLRMT		 produced	in-house	TWINKLE	 produced	in-house	POLγ	 produced	in-house	COX2	 produced	in-house	LRPPRC	 produced	in-house			
Secondary	antibodies		The	following	secondary	antibodies	were	all	purchased	at	GE	Healthcare:	HRP-conjugated	 sheep	 anti	 mouse	 IgG	HRP-conjugated	 donkey	 anti	 rabbit	 IgG	HRP-conjugated	goat	anti	rat	IgG		
	
Oligomers		All	oligomers	were	customized	and	ordered	at	eurofins.	Primers	used	for	genotyping:		
Primer	 																																																	Sequence	5’-3’	TWINKLE	BAC	Forward								 																																					CGACTGAAATCCGCCAGTAT	TWINKLE	BAC	Reverse	 																																				AGAACACAATCCGACGGAAC	MGME1	Lox	P	Forward	 	 GAGGTAGGAGAGGCATGAGG	MGME1	lox	P	Reverse								 																														GGAAGAGAGTTGATGTTCAGGG	MGME1KO	Forward	 	 						GTGGCTGCTTGTCAAACCTT	MGME1KO	Reverse	 	 	ATGTTCAGGGCCAACAGATC	
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5'	Biotinylated	oligomers	for	probing	northern	blots		biotinGCTTTGAAGGCTCTTGGTCTGT	 Trpprobe	biotinCACTCTGCATCAACTGAACGCA	 Alaprobe	biotinGAATGATGGCTAGGGTGACTTC	 ND1probe	biotinTGCTAGGTGTGGTTGGTTGATG	 ND5probe	biotinGGAGAAGATGGTTAGGTCTACG	 COXIprobe	biotinGACTTGGGTTAATCGTGTGACC	 12Sprobe	biotinTGTCTGGTAGTAAGGTGGAGTG	 16Sprobe			Oligomers	for	probing	radioactive	northern	blots					7S	RNA:	5'-GACATATAATATTAACTATCAAACCCTATGTCCTGATCAATTCTA	
	
	
	
Oligomers	capture	7S	ends	
	7S	5’	ends:	GCTGATGGCGATGAATGAACACTGCGTTTGCTGGCTTTGATGAAA	 5'DNA	Adapter	GCTGATGGCGATGAATGAACACTG	5'RACE	Outer	Primer	 	ATCTGGTTCTTACTTCAGGGCCATC	15813fwd	 (PCR/sequencing)		7S	3’	ends:		ACCTATAGTGAGTCGTATTAATTCTGTGCTCGC	 3'DNA	Adapter	(5'	Phosphorylation,	3'	C3	Spacer)	 	 	GCGAGCACAGAATTAATACGACTCACTATAGGTTTTTTTTTTTTVN	 3'oligo	dT	Primer	GCGAGCACAGAATTAATACGACT	 3'RACE	Outer	Primer	GTTTAGCTACCCCCAAGTTTAATGG	15748rev	 (PCR/sequencing)	
			
2.1.3	Plasmids		The	 following	constructs	were	used	 for	generation	of	radiolabeled	probes	and	were	made	without	exception	in	the	department	of	Prof.	Nils	Göran	Larsson:		pCR2.1-cox1	 pCR2.1-cytb	 pCR2.1-12s	 pCR2.1-18s	 pCR2.1-nd1	 pCR–Blunt-II-nd5	 pCR–Blunt-II	-nd6	pCR–Blunt-II	-16s						
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